###begin article-title 0
###xml 98 99 98 99 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fn" rid="fn1">*</xref>
###xml 99 101 99 101 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fn" rid="fn3">S&#8414;</xref>
###xml 101 101 101 101 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fn" rid="fn2"/>
TSG-6 Regulates Bone Remodeling through Inhibition of Osteoblastogenesis and Osteoclast Activation*Sâƒž
###end article-title 0
###begin p 1
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink">1</sup>
###xml 204 232 204 232 <email xmlns:xlink="http://www.w3.org/1999/xlink">anthony.day@manchester.ac.uk</email>
###xml 234 235 234 235 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2</sup>
###xml 328 356 328 356 <email xmlns:xlink="http://www.w3.org/1999/xlink">afsie.sabokbar@ndos.ox.ac.uk</email>
###xml 358 359 358 359 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3</sup>
###xml 563 595 563 595 <email xmlns:xlink="http://www.w3.org/1999/xlink">caroline.milner@manchester.ac.uk</email>
1 To whom correspondence may be addressed: Faculty of Life Sciences, University of Manchester, Michael Smith Bldg., Oxford Rd., Manchester, M13 9PT, UK. Tel.: 44-161-2751495; Fax: 44-161-2751505; E-mail: anthony.day@manchester.ac.uk. 2 To whom correspondence may be addressed. Tel.: 44-1865-227855; Fax: 44-1865-227966; E-mail: afsie.sabokbar@ndos.ox.ac.uk. 3 To whom correspondence may be addressed: Faculty of Life Sciences, University of Manchester, Michael Smith Bldg., Oxford Road, Manchester, M13 9PT, UK. Tel.: 44-161-2755061; Fax: 44-161-2751505; E-mail: caroline.milner@manchester.ac.uk. 
###end p 1
###begin p 2
###xml 0 15 0 15 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Author's Choice</italic>
Author's Choice
###end p 2
###begin p 3
 applies to Author Choice Articles
###end p 3
###begin p 4
###xml 532 537 532 537 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TSG-6</italic>
###xml 537 540 537 540 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 656 661 656 661 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TSG-6</italic>
###xml 661 664 661 664 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 439 444 <span type="species:ncbi:9606">human</span>
###xml 449 455 <span type="species:ncbi:10090">murine</span>
###xml 541 545 <span type="species:ncbi:10090">mice</span>
###xml 665 669 <span type="species:ncbi:10090">mice</span>
###xml 906 910 <span type="species:ncbi:10090">mice</span>
TSG-6 is an inflammation-induced protein that is produced at pathological sites, including arthritic joints. In animal models of arthritis, TSG-6 protects against joint damage; this has been attributed to its inhibitory effects on neutrophil migration and plasmin activity. Here we investigated whether TSG-6 can directly influence bone erosion. Our data reveal that TSG-6 inhibits RANKL-induced osteoclast differentiation/activation from human and murine precursor cells, where elevated dentine erosion by osteoclasts derived from TSG-6-/- mice is consistent with the very severe arthritis seen in these animals. However, the long bones from unchallenged TSG-6-/- mice were found to have higher trabecular mass than controls, suggesting that in the absence of inflammation TSG-6 has a role in bone homeostasis; we have detected expression of the TSG-6 protein in the bone marrow of unchallenged wild type mice. Furthermore, we have observed that TSG-6 can inhibit bone morphogenetic protein-2 (BMP-2)-mediated osteoblast differentiation. Interaction analysis revealed that TSG-6 binds directly to RANKL and to BMP-2 (as well as other osteogenic BMPs but not BMP-3) via composite surfaces involving its Link and CUB modules. Consistent with this, the full-length protein is required for maximal inhibition of osteoblast differentiation and osteoclast activation, although the isolated Link module retains significant activity in the latter case. We hypothesize that TSG-6 has dual roles in bone remodeling; one protective, where it inhibits RANKL-induced bone erosion in inflammatory diseases such as arthritis, and the other homeostatic, where its interactions with BMP-2 and RANKL help to balance mineralization by osteoblasts and bone resorption by osteoclasts.
###end p 4
###begin p 5
###xml 27 58 27 58 <grant-sponsor xmlns:xlink="http://www.w3.org/1999/xlink">Arthritis and Research Campaign</grant-sponsor>
###xml 66 71 66 71 <grant-num xmlns:xlink="http://www.w3.org/1999/xlink">16539</grant-num>
###xml 76 81 76 81 <grant-num xmlns:xlink="http://www.w3.org/1999/xlink">17950</grant-num>
###xml 164 187 164 187 <grant-sponsor xmlns:xlink="http://www.w3.org/1999/xlink">ISIS Innovation, Oxford</grant-sponsor>
###xml 194 201 194 201 <grant-num xmlns:xlink="http://www.w3.org/1999/xlink">POC 228</grant-num>
###xml 259 294 259 294 <grant-sponsor xmlns:xlink="http://www.w3.org/1999/xlink">National Institutes of Health NIAMS</grant-sponsor>
###xml 301 309 301 309 <grant-num xmlns:xlink="http://www.w3.org/1999/xlink">AR051163</grant-num>
###xml 357 365 357 365 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CellProm</italic>
###xml 357 406 357 406 <grant-sponsor xmlns:xlink="http://www.w3.org/1999/xlink"><italic>CellProm</italic> Project, FP6th of the European Community</grant-sponsor>
###xml 408 427 408 427 <grant-num xmlns:xlink="http://www.w3.org/1999/xlink">NMP4-CT-2004-500039</grant-num>
###xml 582 595 582 595 <italic xmlns:xlink="http://www.w3.org/1999/xlink">advertisement</italic>
This work was supported by Arthritis and Research Campaign Grants 16539 and 17950 (to A. J. D. and C. M. M. and to A. S., A. J. D., and C. M. M., respectively) and ISIS Innovation, Oxford Grant POC 228 (to A. S. and A. J. D.). This work was also supported by National Institutes of Health NIAMS Grant AR051163 (to K. M.). Funding was also received from the CellProm Project, FP6th of the European Community (NMP4-CT-2004-500039 (to D. B.)). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
###end p 5
###begin p 6
The on-line version of this article (available at ) contains supplemental Fig. 1.
###end p 6
###begin p 7
###xml 0 15 0 15 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Author's Choice</italic>
Author's Choice-Final version full access.
###end p 7
###begin p 8
###xml 6 7 6 7 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fn" rid="fn4">4</xref>
###xml 75 76 63 64 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref1">1</xref>
###xml 158 159 146 147 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref2">2</xref>
###xml 546 547 530 531 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref1">1</xref>
###xml 549 550 533 534 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref3">3</xref>
###xml 551 553 535 537 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref16">16</xref>
###xml 637 653 621 637 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Escherichia coli</italic>
###xml 676 678 660 662 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref17">17</xref>
###xml 753 755 737 739 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref13">13</xref>
###xml 757 759 741 743 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref14">14</xref>
###xml 761 763 745 747 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref18">18</xref>
###xml 861 862 845 846 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref8">8</xref>
###xml 864 866 848 850 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref19">19</xref>
###xml 868 870 852 854 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref20">20</xref>
###xml 967 969 951 953 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref12">12</xref>
###xml 1124 1125 1108 1109 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fn" rid="fn5">5</xref>
###xml 612 617 <span type="species:ncbi:9606">human</span>
###xml 637 653 <span type="species:ncbi:562">Escherichia coli</span>
###xml 935 940 <span type="species:ncbi:9606">human</span>
TSG-6,4 the approximately35-kDa secreted product of TNF-stimulated gene-6 (1), is expressed in response to various inflammatory mediators and growth factors (2). It is comprised almost entirely of contiguous Link and CUB modules and binds to a diversity of protein and glycosaminoglycan ligands, including pentraxin-3, thrombospondin-1, thrombospondin-2, aggrecan, versican, inter-alpha-inhibitor, bikunin, bone morphogenetic protein-2 (BMP-2), fibronectin, hyaluronan (HA), heparin, heparan sulfate, chondroitin 4-sulfate, and dermatan sulfate (1, 3-16). The three-dimensional structure of the Link module from human TSG-6 (produced in Escherichia coli and termed Link_TSG6 (17)) has been determined by both NMR spectroscopy and x-ray crystallography (13, 14, 18), where the ligand binding sites for HA, bikunin, and heparin have been mapped onto this domain (8, 19, 20). In addition, we have recently expressed the CUB_C domain from human TSG-6 (termed CUB_C_TSG6 (12)), which comprises the CUB module and C-terminal region of the protein, and have used this material to obtain an x-ray structure for the TSG-6 CUB module.5
###end p 8
###begin p 9
###xml 150 151 150 151 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref2">2</xref>
###xml 153 155 153 155 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref21">21</xref>
###xml 157 159 157 159 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref22">22</xref>
###xml 177 179 177 179 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref23">23</xref>
###xml 196 198 196 198 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref24">24</xref>
###xml 200 202 200 202 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref25">25</xref>
###xml 330 332 330 332 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref26">26</xref>
###xml 334 336 334 336 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref27">27</xref>
###xml 591 593 591 593 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref24">24</xref>
###xml 595 597 595 597 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref25">25</xref>
###xml 804 806 801 803 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref28">28</xref>
###xml 808 810 805 807 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref29">29</xref>
###xml 952 954 949 951 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref24">24</xref>
###xml 968 970 965 967 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref30">30</xref>
###xml 1077 1079 1074 1076 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref31">31</xref>
###xml 1080 1082 1077 1079 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref35">35</xref>
###xml 1405 1407 1402 1404 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref31">31</xref>
###xml 1409 1411 1406 1408 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref32">32</xref>
###xml 1512 1514 1509 1511 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref32">32</xref>
###xml 1789 1791 1786 1788 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref34">34</xref>
###xml 2149 2151 2146 2148 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref33">33</xref>
###xml 2290 2292 2287 2289 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref22">22</xref>
###xml 2364 2371 2361 2368 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 2373 2375 2370 2372 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref36">36</xref>
###xml 2376 2378 2373 2375 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref38">38</xref>
###xml 2531 2532 2524 2525 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref8">8</xref>
###xml 2534 2536 2527 2529 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref36">36</xref>
###xml 2538 2540 2531 2533 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref37">37</xref>
###xml 2612 2616 2605 2609 <italic xmlns:xlink="http://www.w3.org/1999/xlink">e.g.</italic>
###xml 2682 2687 2675 2680 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TSG-6</italic>
###xml 2687 2690 2680 2683 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 2958 2960 2951 2953 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref35">35</xref>
###xml 537 545 <span type="species:ncbi:9606">patients</span>
###xml 719 724 <span type="species:ncbi:9606">human</span>
###xml 872 880 <span type="species:ncbi:9606">patients</span>
###xml 1190 1195 <span type="species:ncbi:9606">human</span>
###xml 1320 1335 <span type="species:ncbi:10090">transgenic mice</span>
###xml 1349 1353 <span type="species:ncbi:10090">mice</span>
###xml 1392 1397 <span type="species:ncbi:9606">human</span>
###xml 1506 1510 <span type="species:ncbi:10090">mice</span>
###xml 1545 1560 <span type="species:ncbi:10090">transgenic mice</span>
###xml 1964 1968 <span type="species:ncbi:10090">mice</span>
###xml 1987 1993 <span type="species:ncbi:10090">murine</span>
###xml 2138 2143 <span type="species:ncbi:9606">human</span>
###xml 2691 2695 <span type="species:ncbi:10090">mice</span>
Current data suggest that TSG-6 is not constitutively expressed in normal adult tissues, but rather that it is associated with inflammatory diseases (2, 21, 22) such as asthma (23) and arthritis (24, 25). However, TSG-6 is produced in ovulating ovarian follicles, where it has an essential physiological role in female fertility (26, 27). TSG-6 has been most extensively studied in the context of articular joint disease; it has been detected in the synovial fluid, cartilage, and synovia of osteoarthritis and rheumatoid arthritis (RA) patients but not in the corresponding normal tissues (24, 25). It is likely that TSG-6 is produced locally at disease lesions in joints, as its expression can be induced in cultured human chondrocytes by TNF, IL-1, IL-6, TGF-beta, and platelet-derived growth factor (28, 29), and it is constitutively expressed by synoviocytes from RA patients, where its production is further enhanced by treatment with IL-1, TNF (24), and IL-17 (30). A number of studies have revealed that TSG-6 has a protective role in experimental models of arthritis (31-35). For example, in collagen-induced arthritis (an autoimmune polyarthritis with a histopathology similar to human RA) there was delayed onset of symptoms and reduction of both disease incidence and joint inflammation/destruction in TSG-6 transgenic mice or wild type mice treated systemically with recombinant human TSG-6 (31, 32), where the TSG-6 transgene mediated an effect comparable with anti-TNF antibody treatment in mice (32). In cartilage-specific TSG-6 transgenic mice, the instigation of antigen-induced arthritis (a model of monoarticular arthritis) resulted in delayed cartilage damage compared with controls, with reduced degradation of aggrecan by matrix metalloproteinases and aggrecanases (34). Furthermore, there was evidence of cartilage regeneration 4-5 weeks after the onset of disease in these animals. Similar chondroprotective effects were seen in wild type mice where recombinant murine TSG-6 was injected directly into the affected joint in antigen-induced arthritis or intravenously in proteoglycan-induced arthritis (a model of human RA) (33). The anti-inflammatory and chondroprotective effects of TSG-6 observed in these studies are likely to be due to more than one mechanism (22). For example, TSG-6 is a potent inhibitor of neutrophil extravasation in vivo (36-38) and has also been implicated in the inhibition of the protease network through its potentiation of the anti-plasmin activity of inter-alpha-inhibitor (8, 36, 37), where plasmin is a key regulator of proteolysis during inflammation, e.g. via its activation of matrix metalloproteinases. In this regard, TSG-6-/- mice develop an accelerated and much more severe form of proteoglycan-induced arthritis than controls, having extensive cartilage degradation and bone erosion, which was attributed to increased neutrophil infiltration and plasmin activity in the inflamed paw joints (35).
###end p 9
###begin p 10
###xml 394 398 390 394 <italic xmlns:xlink="http://www.w3.org/1999/xlink">i.e.</italic>
The data presented here demonstrate that TSG-6 inhibits bone erosion by osteoclasts and that this is likely to be mediated via a mechanism that involves its direct interaction with RANKL (the receptor activator of NF-kappaB ligand), the major regulator of osteoclast activity and of joint destruction in arthritis. We have also shown that TSG-6 binds to osteogenic bone morphogenetic proteins (i.e. BMP-2, -4, -5, -6, -7, -13, and -14) and provide evidence that TSG-6 has a physiological role in bone homeostasis via the regulation of both bone formation and resorption.
###end p 10
###begin title 11
EXPERIMENTAL PROCEDURES
###end title 11
###begin p 12
###xml 0 41 0 41 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Preparation of Recombinant TSG-6 Proteins</italic>
###xml 99 109 99 109 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosophila</italic>
###xml 157 159 157 159 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref39">39</xref>
###xml 258 259 258 259 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref1">1</xref>
###xml 324 328 324 328 <italic xmlns:xlink="http://www.w3.org/1999/xlink">i.e.</italic>
###xml 390 397 390 397 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli</italic>
###xml 447 453 447 453 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al.</italic>
###xml 455 457 455 457 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref17">17</xref>
###xml 468 474 468 474 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al.</italic>
###xml 476 478 476 478 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref40">40</xref>
###xml 499 505 499 505 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al.</italic>
###xml 507 509 507 509 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref12">12</xref>
###xml 66 71 <span type="species:ncbi:9606">human</span>
###xml 99 109 <span type="species:ncbi:7227">Drosophila</span>
###xml 192 197 <span type="species:ncbi:9606">human</span>
###xml 353 358 <span type="species:ncbi:9606">human</span>
###xml 390 397 <span type="species:ncbi:562">E. coli</span>
Preparation of Recombinant TSG-6 Proteins-Full-length recombinant human (rh)TSG-6 was expressed in Drosophila S2 cells and purified as described previously (39). Link_TSG6 (the Link module of human TSG-6, corresponding to residues 36-133 of the pre-protein (1)) and CUB_C_TSG6 (the CUB domain and C-terminal 27 amino acids; i.e. residues 129-277 of the human pre-protein) were expressed in E. coli, purified, and characterized as described in Day et al. (17), Kahmann et al. (40), and in Kuznetsova et al. (12), respectively.
###end p 12
###begin p 13
###xml 0 59 0 59 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Effect of TSG-6 on RANKL-induced Human Osteoclast Formation</italic>
###xml 295 297 295 297 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref41">41</xref>
###xml 491 492 483 484 <italic xmlns:xlink="http://www.w3.org/1999/xlink">g</italic>
###xml 685 686 673 674 <sup xmlns:xlink="http://www.w3.org/1999/xlink">5</sup>
###xml 1059 1062 1039 1042 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m l</sc>
###xml 1296 1298 1275 1277 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref39">39</xref>
###xml 1367 1369 1346 1348 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref17">17</xref>
###xml 1397 1399 1376 1378 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref12">12</xref>
###xml 33 38 <span type="species:ncbi:9606">Human</span>
###xml 111 116 <span type="species:ncbi:9606">human</span>
###xml 139 144 <span type="species:ncbi:9606">human</span>
###xml 569 573 <span type="species:ncbi:9913">calf</span>
###xml 1043 1047 <span type="species:ncbi:9913">calf</span>
Effect of TSG-6 on RANKL-induced Human Osteoclast Formation-To determine the effects of TSG-6 on RANKL-induced human osteoclast formation, human peripheral blood mononuclear cells (PBMCs) were isolated from healthy male volunteers (age range 25-35 years) as described in Sabokbar and Athanasou (41). Briefly, blood was collected in EDTA-treated tubes and diluted 1:1 in alpha-minimum essential medium (alphaMEM) (Invitrogen), layered over Histopaque (Sigma-Aldrich), then centrifuged (693 x g), washed, and resuspended in alphaMEM with 10% (v/v) heat-inactivated fetal calf serum (Invitrogen). PBMCs were counted after lysis of red cells with 5% (v/v) acetic acid and seeded (at 5 x 105 cells/well) into 96-well tissue culture plates containing either dentine slices or coverslips. After 2 h of incubation, dentine slices and coverslips were removed from the wells and washed vigorously in alphaMEM to remove non-adherent cells before transfer into 24-well tissue culture plates containing 1 ml/well alphaMEM supplemented with 10% (v/v) fetal calf serum, 10 mm l-glutamine, antibiotics (100 IU/ml penicillin and 10 mug/ml streptomycin), 25 ng/ml macrophage colony-stimulating factor (M-CSF; R&D Systems Europe), and 50 ng/ml soluble (s)RANKL (PeproTech). After the addition of rhTSG-6 (30.1 kDa (39)) at 0-50 ng/ml or equimolar concentrations of Link_TSG6 (10.9 kDa (17)) or CUB_C_TSG6 (16.8 kDa (12)), cultures were maintained for up to 21 days, during which time the entire culture medium containing all factors was replenished every 2-3 days.
###end p 13
###begin p 14
###xml 293 294 293 294 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 347 348 347 348 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 592 593 592 593 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 596 597 596 597 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4</sub>
Osteoclast formation was assessed cytochemically by determining the number of multinucleated tartrate-resistant acid phosphatase-positive cells after 14 days in culture. Cells on coverslips were fixed in 10% (v/v) formalin and stained using napthol AS-BI as a substrate in the presence of 1.0 m acetate-tartrate; the reaction was stopped with 0.5 m NaF. Bone resorptive activity, an indicator of osteoclast activation, was determined by the measurement of resorption lacunae on dentine slices. After 21 days in culture dentine slices were removed from the wells, rinsed in PBS, placed in 1.0 m NH4OH overnight, and then sonicated for 5-10 min; this resulted in complete removal of cells from the dentine slice, permitting examination of its surface. The slices were washed in distilled water, stained with 0.5% (w/v) aqueous toluidine blue, pH 5.0, and examined by light microscopy. Tartrate-resistant acid phosphatase staining was analyzed using ImageJ software (), whereas for lacunar resorption the data were expressed as the mean percentage area resorbed from four dentine slices per treatment. Each set of experiments was repeated at least three times.
###end p 14
###begin p 15
###xml 0 54 0 54 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Extent of Osteoclast Formation in TSG-6-deficient Mice</italic>
###xml 55 60 55 60 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TSG-6</italic>
###xml 60 63 60 63 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 109 111 109 111 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref27">27</xref>
###xml 158 160 158 160 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref35">35</xref>
###xml 191 196 191 196 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TSG-6</italic>
###xml 196 199 196 199 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 482 487 482 487 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TSG-6</italic>
###xml 487 490 487 490 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 535 537 535 537 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref42">42</xref>
###xml 571 572 571 572 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 1026 1027 1022 1023 <sup xmlns:xlink="http://www.w3.org/1999/xlink">4</sup>
###xml 50 54 <span type="species:ncbi:10090">Mice</span>
###xml 64 68 <span type="species:ncbi:10090">mice</span>
###xml 226 230 <span type="species:ncbi:10090">mice</span>
###xml 491 495 <span type="species:ncbi:10090">mice</span>
###xml 549 553 <span type="species:ncbi:10090">mice</span>
###xml 1426 1432 <span type="species:ncbi:10090">murine</span>
Extent of Osteoclast Formation in TSG-6-deficient Mice-TSG-6-/- mice were generated as described previously (27) and back-crossed into the BALB/c background (35). Age-matched pairs of female TSG-6-/- and wild type (WT) BALB/c mice (between 18 and 25 weeks of age) were used for experiments. All procedures carried out on animals were approved by the Institutional Animal Care and Use Committee (Rush University Medical Center, Chicago, IL). Bone marrow cells from the long bones of TSG-6-/- mice were isolated as previously described (42). Briefly, mice were killed by CO2 inhalation, and the femora and tibiae were aseptically removed and dissected free of adherent soft tissue. The bone ends were cut, and the marrow cavity was flushed out into a Petri dish by slowly injecting alphaMEM at one end of the bone using a sterile 21-gauge needle. The bone marrow suspension was carefully agitated with a plastic Pasteur pipette to obtain a homogeneous suspension of cells, and these were incubated for 2 h at a density of 5 x 104 cells/ml in 96-well plates containing dentine slices. Non-adherent cells were removed from the dentine slices (by vigorous washing in alphaMEM), which were then transferred to 24-well plates containing alphaMEM with 10% (v/v) heat-inactivated serum and antibiotics (as described above). Cultures on dentine slices were maintained in the presence of 25 ng/ml M-CSF (R&D Systems Europe) and 30 ng/ml murine sRANKL (PeproTech) for 10 days during which the culture media and factors were replenished every 2-3 days. The extent of lacunar resorption was then determined as described above.
###end p 15
###begin p 16
###xml 0 90 0 90 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Micro-computerized Tomography (CT) Analysis of Long Bones from TSG-6-deficient and WT Mice</italic>
###xml 438 439 436 437 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2</sup>
###xml 761 763 759 761 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref43">43</xref>
###xml 790 792 788 790 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref44">44</xref>
###xml 86 90 <span type="species:ncbi:10090">Mice</span>
###xml 153 158 <span type="species:ncbi:10090">mouse</span>
###xml 260 264 <span type="species:ncbi:10090">mice</span>
Micro-computerized Tomography (CT) Analysis of Long Bones from TSG-6-deficient and WT Mice-Micro-CT analysis of the long bones in TSG-6-deficient and WT mouse femurs was performed to determine any differences in trabecular bone; four pairs of age-matched male mice (24-28 weeks) were analyzed. Briefly, plastic-wrapped knees were mounted vertically on a Skyscan 1172 micro-CT scanner and scans (6.77 mum with a voxel resolution of 6.9 mum2) were performed using a 20-100-kV microfocus x-ray source with a 10-megapixel digital x-ray camera. The images obtained were subjected to three-dimensional angular resampling (using Skyscan 3D-creator software), and morphometric parameters were calculated for trabecular regions of interest using a Marching Cubes model (43) as described previously (44).
###end p 16
###begin p 17
###xml 0 51 0 51 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Immunolocalization of TSG-6 in the Mouse Knee Joint</italic>
###xml 152 158 152 158 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al.</italic>
###xml 160 162 160 162 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref45">45</xref>
###xml 757 759 756 758 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref39">39</xref>
###xml 1286 1292 1283 1289 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al.</italic>
###xml 1294 1296 1291 1293 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref45">45</xref>
###xml 1439 1441 1436 1438 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref45">45</xref>
###xml 35 40 <span type="species:ncbi:10090">Mouse</span>
###xml 52 57 <span type="species:ncbi:10090">Mouse</span>
###xml 174 179 <span type="species:ncbi:10090">mouse</span>
###xml 475 481 <span type="species:ncbi:9986">rabbit</span>
###xml 717 723 <span type="species:ncbi:10090">murine</span>
###xml 840 844 <span type="species:ncbi:9925">goat</span>
###xml 934 938 <span type="species:ncbi:9925">goat</span>
###xml 944 950 <span type="species:ncbi:9986">rabbit</span>
###xml 1077 1083 <span type="species:ncbi:9913">bovine</span>
Immunolocalization of TSG-6 in the Mouse Knee Joint-Mouse knee joints were prepared for confocal immunohistochemistry essentially as described in Plaas et al. (45). Briefly, mouse legs were fixed in 10% (v/v) neutral-buffered formalin for 48 h, skin and muscle tissue were removed, and joints were decalcified in 5% (w/v) EDTA in PBS for 14 days. Specimens were then processed and embedded in paraffin. Thin sections (4 mum) were deparaffinized, rehydrated, and exposed to a rabbit anti-TSG-6 polyclonal antibody (prepared in collaboration with Dr. J. D. Sandy (Rush University, Chicago, IL) and Affinity Bioreagents (Golden, CO) against the peptide ASVTAGGFQIK, affinity-purified, and shown to recognize recombinant murine TSG-6 (R&D Systems) and rhTSG-6 (39) by Western blotting; see supplemental Fig. 1) at 10 mug/ml (IgG) in 1.5% (v/v) goat serum in PBS for 30 min, washed in PBS for 5 min, and then incubated with AlexaFluor-568 goat anti-rabbit IgG (Molecular Probes; 1:250 in PBS) for 1 h at room temperature. Sections were co-stained for HA using 5 mug/ml biotinylated bovine cartilage HA-binding protein/link protein complexes (isolated in the A1A1D6 fraction after CsCl gradient centrifugation) followed by AlexaFluor-488-streptavidin (Molecular Probes) as described in Plaas et al. (45). Nuclei were stained with TOTO-3 (Molecular Probes; 1:500 in PBS), and sections were examined by confocal microscopy as detailed previously (45).
###end p 17
###begin p 18
###xml 0 59 0 59 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Effect of TSG-6 on BMP-2-induced Osteoblast Differentiation</italic>
###xml 135 137 135 137 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref46">46</xref>
###xml 191 193 191 193 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref47">47</xref>
###xml 235 236 235 236 <sup xmlns:xlink="http://www.w3.org/1999/xlink">4</sup>
###xml 367 370 367 370 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m l</sc>
###xml 735 736 734 735 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 1261 1262 1250 1251 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 1343 1344 1331 1332 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 1489 1490 1470 1471 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 1493 1494 1474 1475 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 1496 1497 1477 1478 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 60 66 <span type="species:ncbi:10090">Murine</span>
###xml 336 342 <span type="species:ncbi:9913">bovine</span>
Effect of TSG-6 on BMP-2-induced Osteoblast Differentiation-Murine MC3T3-E1 osteoblastic cells (European Collection of Cell Cultures) (46) and MBA-15.4 pre-osteoblastic marrow-derived cells (47) were seeded on 24-well plates (1.25 x 104 cells/ml) in Dulbecco's modified Eagle's medium supplemented with 10% (v/v) heat-inactivated fetal bovine serum (Invitrogen), 10 mm l-glutamine, and antibiotics (100 IU/ml penicillin and 10 mug/ml streptomycin). Differentiation into osteoblasts was induced with 100 ng/ml BMP-2 (R&D Systems Europe), and the effects of adding rhTSG-6 (0-10000 ng/ml) or molar equivalents of Link_TSG6 or CUB_C_TSG6 proteins were determined. Cells were cultured for 7 days in a humidified atmosphere with 5% (v/v) CO2 at 37 degreesC, during which time the culture media (including all factors) was replaced every 72 h. Cells were washed in PBS and freeze-thawed 3 times, and alkaline phosphatase (ALP) was released by scraping cells into 50 mul of 0.2% (v/v) Nonidet P-40 (Fluka) and subsequent sonication (5 s at 6 watts). ALP activity (pmol/mul of material) was determined using the fluorescent substrate 4-methyl umbelliferyl phosphate (Sigma-Aldrich). Briefly, 10 mul of cell lysate was diluted in 50 mul of 0.16% (v/v) Nonidet P-40, 10 mm Tris, pH 8.0, in the wells of a Nunclon Delta (Nunc) plate, and 100 mul of 0.2 mm methyl umbelliferyl phosphate was added. Plates were incubated at 37 degreesC for 45 min, and the reaction was stopped by adding 100 mul of 0.6 m Na2CO3 to each well. Fluorescence was measured using an excitation wavelength of 360 nm and an emission wavelength of 450 nm (with a 435 nm cutoff) on a SPECTRAmax GEMINI microplate spectrofluorometer. The yield of ALP was calculated by the preparation of a standard curve of 0-1000 pmol of 4-methyl umbelliferyl phosphate (Sigma) on the same plate and standardized against the total amount of protein/well (in mug), determined using a BCA protein assay kit (Pierce).
###end p 18
###begin p 19
###xml 0 19 0 19 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TSG-6 Binding ELISA</italic>
###xml 942 944 936 938 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref48">48</xref>
###xml 1167 1169 1161 1163 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref49">49</xref>
###xml 1326 1327 1319 1320 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 1385 1386 1378 1379 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 1401 1402 1394 1395 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 1412 1413 1405 1406 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 1418 1419 1411 1412 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 1422 1423 1415 1416 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 1603 1607 1596 1600 <italic xmlns:xlink="http://www.w3.org/1999/xlink">i.e.</italic>
###xml 680 686 <span type="species:ncbi:9913">bovine</span>
###xml 905 911 <span type="species:ncbi:9986">rabbit</span>
###xml 1021 1025 <span type="species:ncbi:9925">goat</span>
###xml 1031 1037 <span type="species:ncbi:9986">rabbit</span>
###xml 1230 1234 <span type="species:ncbi:9925">goat</span>
###xml 1240 1243 <span type="species:ncbi:10116">rat</span>
TSG-6 Binding ELISA-The BMP and sRANKL binding activities of TSG-6 and its individual domains were determined colorimetrically using ELISAs. All dilutions, incubations, and washes were performed in standard assay buffer (SAB; PBS containing 0.2% (v/v) Tween 20) and at room temperature unless otherwise indicated. BMPs (-2, -13, and -14 from PeproTech; -3, -4, -5, -6, and -7 from R&D Systems Europe) or sRANKL (PeproTech) were coated overnight on Polysorp (Nunc) microtiter plates (0-30 pmol/well) in PBS at room temperature. After this and all subsequent steps, wells were washed three times with SAB. All wells were blocked for 90 min at 37 degreesC in SAB containing 1% (w/v) bovine serum albumin and then incubated for 4 h with rhTSG-6, Link_TSG6, or CUB_C_TSG6 at 2 or 5 pmol/well for the BMP and sRANKL assays, respectively. Bound TSG-6 and CUB_C_TSG6 were compared by incubation for 45 min with a rabbit polyclonal antiserum (RAH-1) (48) diluted 1:4000 followed by incubation with alkaline phosphatase-conjugated goat anti-rabbit IgG (1:2000; Sigma-Aldrich) for an additional 45 min. Bound Link_TSG6 and TSG-6 were compared using the monoclonal antibody Q75 (49) at 1.25 mug/ml followed by alkaline phosphatase-conjugated goat anti-rat IgG (1:2000; Sigma-Aldrich), where these were incubated for 45 min each. Disodium p-nitrophenyl phosphate (Sigma-Aldrich) at 1 mg/ml in 0.05 m Tris-HCl, 0.1 m NaCl, 5 mm MgCl2.6H2O, pH 9.3, was added, and absorbance values at 405 nm were measured after 30 or 60 min of incubation (for BMP and sRANKL ELISAs, respectively) and corrected against control wells (i.e. those containing no immobilized protein).
###end p 19
###begin p 20
###xml 0 20 0 20 <italic xmlns:xlink="http://www.w3.org/1999/xlink">sRANKL Binding ELISA</italic>
###xml 353 359 353 359 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al.</italic>
###xml 361 363 361 363 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref19">19</xref>
sRANKL Binding ELISA-TSG-6 or its individual protein domains (0-30 pmol/well) were coated overnight onto microtiter plates, blocked, and washed as described above. All wells were incubated with 30 ng/well biotinylated-sRANKL (PeproTech) for 4 h, and bound sRANKL was detected with ExtrAvidin alkaline phosphatase (Sigma-Aldrich) as described in Mahoney et al. (19) except that absorbance values at 405 nm were measured after a 60-min development time.
###end p 20
###begin p 21
###xml 0 25 0 25 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Surface Plasmon Resonance</italic>
###xml 114 115 114 115 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 136 137 136 137 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 147 148 147 148 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 250 251 248 249 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 269 270 266 267 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 371 372 368 369 <italic xmlns:xlink="http://www.w3.org/1999/xlink">N</italic>
###xml 529 530 525 526 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
Surface Plasmon Resonance-All experiments were performed on a BIACore 2000 system in HEPES-EP running buffer (10 mm HEPES, pH 7.4, 150 mm NaCl, 3 mm EDTA, 0.005% (v/v) surfactant P20) at a constant flow rate of 10 mul/min. BMPs or sRANKL (0.37-0.5 mum in 40 mul of 10 mm sodium acetate, pH 4.0) were coupled onto commercially available CM5 sensor chips preactivated with N-hydroxysuccinimide and 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide. After immobilization of these proteins, binding analyses were performed using 0-10 mum rhTSG-6, Link_TSG6, or CUB_C_TSG6, where 100 mul of the protein solution was passed over the sensor chip surface, and maximum equilibrium binding was determined 600 s after the start of the injection. Scatchard analysis was performed to determine the validity of the 1:1 Langmuir association/dissociation model, and data were analyzed with Origin software (MicroCal) using a sum of least squares iterative improvement method. These experiments were performed twice, and an average dissociation constant was calculated.
###end p 21
###begin p 22
###xml 0 20 0 20 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Statistical Analysis</italic>
###xml 184 192 184 192 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 269 270 269 270 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t</italic>
###xml 321 322 321 322 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 461 462 461 462 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
Statistical Analysis-All data were normalized and expressed as percentages relative to controls. Each set of experiments was repeated at least three times unless otherwise stated. For in vitro work, differences between groups were analyzed using the unpaired Student's t test or a Tukey-Kramer multiple comparisons test. p < 0.01 was considered significant. For the histomorphometric analysis of distal femurs, a non-parametrical Kruskall-Wallis test was used; p < 0.05 was considered significant.
###end p 22
###begin title 23
RESULTS
###end title 23
###begin p 24
###xml 0 67 0 67 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Effect of TSG-6 on sRANKL-induced Osteoclast Formation and Activity</italic>
###xml 436 438 436 438 <sub xmlns:xlink="http://www.w3.org/1999/xlink">50</sub>
###xml 489 490 465 466 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 520 521 496 497 <italic xmlns:xlink="http://www.w3.org/1999/xlink">a</italic>
###xml 526 527 502 503 <italic xmlns:xlink="http://www.w3.org/1999/xlink">b</italic>
###xml 511 527 487 503 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Figs. 1, <italic>a</italic> and <italic>b</italic></xref>
###xml 755 756 731 732 <italic xmlns:xlink="http://www.w3.org/1999/xlink">c</italic>
###xml 749 756 725 732 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1<italic>c</italic></xref>
###xml 844 845 820 821 <italic xmlns:xlink="http://www.w3.org/1999/xlink">b</italic>
###xml 838 845 814 821 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1<italic>b</italic></xref>
###xml 1084 1090 1060 1066 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2</xref>
###xml 68 73 <span type="species:ncbi:9606">Human</span>
Effect of TSG-6 on sRANKL-induced Osteoclast Formation and Activity-Human PBMCs were incubated with M-CSF and sRANKL for 14 days on coverslips to allow visualization of newly differentiated osteoclasts or for 21 days on dentine slices to assay for activity in the form of lacunar resorption. The addition of full-length rhTSG-6 to these cultures resulted in a dose-dependent inhibition of osteoclast-mediated dentine erosion, with an IC50 value of approximately15 ng/ml (approximately0.5 nm), as illustrated in Figs. 1, a and b. There was no apparent reduction in the number or the size of the multinucleated osteoclasts formed in TSG-6-treated cultures, as assessed by staining of cells grown on coverslips for tartrate-resistant acid phosphatase (Fig. 1c); in contrast, lacunar resorption was markedly reduced in the presence of TSG-6 (Fig. 1b). Overall these findings suggest that TSG-6 affects osteoclast activation rather than differentiation. A comparison of the effects of rhTSG-6 with equimolar quantities of Link_TSG6 and CUB_C_TSG6 on sRANKL-induced lacunar resorption (see Fig. 2) revealed that the isolated CUB_C domain has little effect on osteoclast function. In contrast, the Link module retains significant activity, although this is less than that of the intact protein.
###end p 24
###begin p 25
###xml 0 9 0 9 <label xmlns:xlink="http://www.w3.org/1999/xlink">FIGURE 1.</label>
###xml 9 58 9 58 <bold xmlns:xlink="http://www.w3.org/1999/xlink">TSG-6 inhibits RANKL-mediated osteoclastogenesis.</bold>
###xml 58 59 58 59 <italic xmlns:xlink="http://www.w3.org/1999/xlink">a</italic>
###xml 333 334 333 334 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 389 391 387 389 <sup xmlns:xlink="http://www.w3.org/1999/xlink">**</sup>
###xml 396 399 394 397 <sup xmlns:xlink="http://www.w3.org/1999/xlink">***</sup>
###xml 402 403 400 401 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 412 413 410 411 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 437 438 435 436 <italic xmlns:xlink="http://www.w3.org/1999/xlink">b</italic>
###xml 443 444 441 442 <italic xmlns:xlink="http://www.w3.org/1999/xlink">c</italic>
###xml 513 514 511 512 <italic xmlns:xlink="http://www.w3.org/1999/xlink">b</italic>
###xml 531 532 529 530 <italic xmlns:xlink="http://www.w3.org/1999/xlink">c</italic>
###xml 719 720 717 718 <italic xmlns:xlink="http://www.w3.org/1999/xlink">b</italic>
###xml 806 807 804 805 <italic xmlns:xlink="http://www.w3.org/1999/xlink">c</italic>
###xml 9 823 9 821 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="26"><bold>TSG-6 inhibits RANKL-mediated osteoclastogenesis.</bold><italic>a</italic>, human PBMCs were cultured with sRANKL and M-CSF in the absence or presence of rhTSG-6 (0&#8211;50 ng/ml) for 21 days on dentine slices. Lacunar resorption was assessed by light microscopy following staining with toluidine blue. Data are expressed as mean percentage resorption (<italic>n</italic> = 9) &#177; S.E., compared with RANKL/M-CSF alone, where <sup>**</sup> and <sup>***</sup> = <italic>p</italic> &lt; 0.01, <italic>p</italic> &lt; 0.001, respectively. <italic>b</italic> and <italic>c</italic>, human PBMCs were cultured with sRANKL and M-CSF on dentine slices (<italic>b</italic>) or coverslips (<italic>c</italic>) for 21 or 14 days, respectively, in the absence (-) or presence (+) of rhTSG-6 (50 ng). Osteoclast formation or activation was assessed by determining the extent of lacunar resorption (<italic>b</italic>) or the number of tartrate-resistant acid phosphatase-positive multinucleated cells (<italic>c</italic>), respectively.</p>
###xml 9 823 9 821 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="26"><bold>TSG-6 inhibits RANKL-mediated osteoclastogenesis.</bold><italic>a</italic>, human PBMCs were cultured with sRANKL and M-CSF in the absence or presence of rhTSG-6 (0&#8211;50 ng/ml) for 21 days on dentine slices. Lacunar resorption was assessed by light microscopy following staining with toluidine blue. Data are expressed as mean percentage resorption (<italic>n</italic> = 9) &#177; S.E., compared with RANKL/M-CSF alone, where <sup>**</sup> and <sup>***</sup> = <italic>p</italic> &lt; 0.01, <italic>p</italic> &lt; 0.001, respectively. <italic>b</italic> and <italic>c</italic>, human PBMCs were cultured with sRANKL and M-CSF on dentine slices (<italic>b</italic>) or coverslips (<italic>c</italic>) for 21 or 14 days, respectively, in the absence (-) or presence (+) of rhTSG-6 (50 ng). Osteoclast formation or activation was assessed by determining the extent of lacunar resorption (<italic>b</italic>) or the number of tartrate-resistant acid phosphatase-positive multinucleated cells (<italic>c</italic>), respectively.</p></caption>
###xml 823 823 821 821 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="zbc0370847930001"/>
###xml 0 823 0 821 <fig xmlns:xlink="http://www.w3.org/1999/xlink" position="float" id="fig1"><label>FIGURE 1.</label><caption><p textid="26"><bold>TSG-6 inhibits RANKL-mediated osteoclastogenesis.</bold><italic>a</italic>, human PBMCs were cultured with sRANKL and M-CSF in the absence or presence of rhTSG-6 (0&#8211;50 ng/ml) for 21 days on dentine slices. Lacunar resorption was assessed by light microscopy following staining with toluidine blue. Data are expressed as mean percentage resorption (<italic>n</italic> = 9) &#177; S.E., compared with RANKL/M-CSF alone, where <sup>**</sup> and <sup>***</sup> = <italic>p</italic> &lt; 0.01, <italic>p</italic> &lt; 0.001, respectively. <italic>b</italic> and <italic>c</italic>, human PBMCs were cultured with sRANKL and M-CSF on dentine slices (<italic>b</italic>) or coverslips (<italic>c</italic>) for 21 or 14 days, respectively, in the absence (-) or presence (+) of rhTSG-6 (50 ng). Osteoclast formation or activation was assessed by determining the extent of lacunar resorption (<italic>b</italic>) or the number of tartrate-resistant acid phosphatase-positive multinucleated cells (<italic>c</italic>), respectively.</p></caption><graphic xlink:href="zbc0370847930001"/></fig>
###xml 61 66 <span type="species:ncbi:9606">human</span>
###xml 446 451 <span type="species:ncbi:9606">human</span>
FIGURE 1.TSG-6 inhibits RANKL-mediated osteoclastogenesis.a, human PBMCs were cultured with sRANKL and M-CSF in the absence or presence of rhTSG-6 (0-50 ng/ml) for 21 days on dentine slices. Lacunar resorption was assessed by light microscopy following staining with toluidine blue. Data are expressed as mean percentage resorption (n = 9) +/- S.E., compared with RANKL/M-CSF alone, where ** and *** = p < 0.01, p < 0.001, respectively. b and c, human PBMCs were cultured with sRANKL and M-CSF on dentine slices (b) or coverslips (c) for 21 or 14 days, respectively, in the absence (-) or presence (+) of rhTSG-6 (50 ng). Osteoclast formation or activation was assessed by determining the extent of lacunar resorption (b) or the number of tartrate-resistant acid phosphatase-positive multinucleated cells (c), respectively.
###end p 25
###begin p 26
###xml 0 49 0 49 <bold xmlns:xlink="http://www.w3.org/1999/xlink">TSG-6 inhibits RANKL-mediated osteoclastogenesis.</bold>
###xml 49 50 49 50 <italic xmlns:xlink="http://www.w3.org/1999/xlink">a</italic>
###xml 324 325 324 325 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 380 382 378 380 <sup xmlns:xlink="http://www.w3.org/1999/xlink">**</sup>
###xml 387 390 385 388 <sup xmlns:xlink="http://www.w3.org/1999/xlink">***</sup>
###xml 393 394 391 392 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 403 404 401 402 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 428 429 426 427 <italic xmlns:xlink="http://www.w3.org/1999/xlink">b</italic>
###xml 434 435 432 433 <italic xmlns:xlink="http://www.w3.org/1999/xlink">c</italic>
###xml 504 505 502 503 <italic xmlns:xlink="http://www.w3.org/1999/xlink">b</italic>
###xml 522 523 520 521 <italic xmlns:xlink="http://www.w3.org/1999/xlink">c</italic>
###xml 710 711 708 709 <italic xmlns:xlink="http://www.w3.org/1999/xlink">b</italic>
###xml 797 798 795 796 <italic xmlns:xlink="http://www.w3.org/1999/xlink">c</italic>
###xml 52 57 <span type="species:ncbi:9606">human</span>
###xml 437 442 <span type="species:ncbi:9606">human</span>
TSG-6 inhibits RANKL-mediated osteoclastogenesis.a, human PBMCs were cultured with sRANKL and M-CSF in the absence or presence of rhTSG-6 (0-50 ng/ml) for 21 days on dentine slices. Lacunar resorption was assessed by light microscopy following staining with toluidine blue. Data are expressed as mean percentage resorption (n = 9) +/- S.E., compared with RANKL/M-CSF alone, where ** and *** = p < 0.01, p < 0.001, respectively. b and c, human PBMCs were cultured with sRANKL and M-CSF on dentine slices (b) or coverslips (c) for 21 or 14 days, respectively, in the absence (-) or presence (+) of rhTSG-6 (50 ng). Osteoclast formation or activation was assessed by determining the extent of lacunar resorption (b) or the number of tartrate-resistant acid phosphatase-positive multinucleated cells (c), respectively.
###end p 26
###begin p 27
###xml 0 58 0 58 <italic xmlns:xlink="http://www.w3.org/1999/xlink">sRANKL-mediated Osteoclastogenesis in TSG-6-deficient Mice</italic>
###xml 107 112 107 112 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TSG-6</italic>
###xml 112 115 112 115 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 396 397 396 397 <italic xmlns:xlink="http://www.w3.org/1999/xlink">a</italic>
###xml 390 397 390 397 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3<italic>a</italic></xref>
###xml 491 493 491 493 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref35">35</xref>
###xml 54 58 <span type="species:ncbi:10090">Mice</span>
###xml 116 120 <span type="species:ncbi:10090">mice</span>
###xml 289 293 <span type="species:ncbi:10090">mice</span>
sRANKL-mediated Osteoclastogenesis in TSG-6-deficient Mice-Cells isolated from the marrow of long bones of TSG-6-/- mice or wild type BALB/c animals (WT) were cultured on dentine slices in the presence of M-CSF and sRANKL for 10 days. In the case of the cells derived from TSG-6-deficient mice there was substantially elevated osteoclast-mediated lacunar resorption compared with controls (Fig. 3a), which is consistent with the severe arthritis and tissue damage reported in these animals (35).
###end p 27
###begin p 28
###xml 0 9 0 9 <label xmlns:xlink="http://www.w3.org/1999/xlink">FIGURE 2.</label>
###xml 9 97 9 97 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Full-length TSG-6 and its isolated Link module inhibit RANKL-induced lacunar resorption.</bold>
###xml 417 418 417 418 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 441 443 439 441 <sup xmlns:xlink="http://www.w3.org/1999/xlink">**</sup>
###xml 448 451 446 449 <sup xmlns:xlink="http://www.w3.org/1999/xlink">***</sup>
###xml 454 455 452 453 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 467 468 465 466 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 9 491 9 489 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="29"><bold>Full-length TSG-6 and its isolated Link module inhibit RANKL-induced lacunar resorption.</bold> rhTSG-6 (0&#8211;50 ng/ml) or equimolar concentrations of Link_TSG6 (Link) or CUB_C_TSG6 (CUB_C) were added to cultures of human PBMCs in the presence of sRANKL and M-CSF. The extent of lacunar resorption of dentine slices was assessed after 21 days. Data are expressed as the mean percentage of resorption with RANKL alone (<italic>n</italic> = 12) &#177; S.E., where <sup>**</sup> and <sup>***</sup> = <italic>p</italic> &lt; 0.01 and <italic>p</italic> &lt; 0.001, respectively.</p>
###xml 9 491 9 489 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="29"><bold>Full-length TSG-6 and its isolated Link module inhibit RANKL-induced lacunar resorption.</bold> rhTSG-6 (0&#8211;50 ng/ml) or equimolar concentrations of Link_TSG6 (Link) or CUB_C_TSG6 (CUB_C) were added to cultures of human PBMCs in the presence of sRANKL and M-CSF. The extent of lacunar resorption of dentine slices was assessed after 21 days. Data are expressed as the mean percentage of resorption with RANKL alone (<italic>n</italic> = 12) &#177; S.E., where <sup>**</sup> and <sup>***</sup> = <italic>p</italic> &lt; 0.01 and <italic>p</italic> &lt; 0.001, respectively.</p></caption>
###xml 491 491 489 489 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="zbc0370847930002"/>
###xml 0 491 0 489 <fig xmlns:xlink="http://www.w3.org/1999/xlink" position="float" id="fig2"><label>FIGURE 2.</label><caption><p textid="29"><bold>Full-length TSG-6 and its isolated Link module inhibit RANKL-induced lacunar resorption.</bold> rhTSG-6 (0&#8211;50 ng/ml) or equimolar concentrations of Link_TSG6 (Link) or CUB_C_TSG6 (CUB_C) were added to cultures of human PBMCs in the presence of sRANKL and M-CSF. The extent of lacunar resorption of dentine slices was assessed after 21 days. Data are expressed as the mean percentage of resorption with RANKL alone (<italic>n</italic> = 12) &#177; S.E., where <sup>**</sup> and <sup>***</sup> = <italic>p</italic> &lt; 0.01 and <italic>p</italic> &lt; 0.001, respectively.</p></caption><graphic xlink:href="zbc0370847930002"/></fig>
###xml 215 220 <span type="species:ncbi:9606">human</span>
FIGURE 2.Full-length TSG-6 and its isolated Link module inhibit RANKL-induced lacunar resorption. rhTSG-6 (0-50 ng/ml) or equimolar concentrations of Link_TSG6 (Link) or CUB_C_TSG6 (CUB_C) were added to cultures of human PBMCs in the presence of sRANKL and M-CSF. The extent of lacunar resorption of dentine slices was assessed after 21 days. Data are expressed as the mean percentage of resorption with RANKL alone (n = 12) +/- S.E., where ** and *** = p < 0.01 and p < 0.001, respectively.
###end p 28
###begin p 29
###xml 0 88 0 88 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Full-length TSG-6 and its isolated Link module inhibit RANKL-induced lacunar resorption.</bold>
###xml 408 409 408 409 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 432 434 430 432 <sup xmlns:xlink="http://www.w3.org/1999/xlink">**</sup>
###xml 439 442 437 440 <sup xmlns:xlink="http://www.w3.org/1999/xlink">***</sup>
###xml 445 446 443 444 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 458 459 456 457 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 206 211 <span type="species:ncbi:9606">human</span>
Full-length TSG-6 and its isolated Link module inhibit RANKL-induced lacunar resorption. rhTSG-6 (0-50 ng/ml) or equimolar concentrations of Link_TSG6 (Link) or CUB_C_TSG6 (CUB_C) were added to cultures of human PBMCs in the presence of sRANKL and M-CSF. The extent of lacunar resorption of dentine slices was assessed after 21 days. Data are expressed as the mean percentage of resorption with RANKL alone (n = 12) +/- S.E., where ** and *** = p < 0.01 and p < 0.001, respectively.
###end p 29
###begin p 30
###xml 0 37 0 37 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Micro-CT Analysis of Bones from TSG-6</italic>
###xml 37 38 37 38 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 38 39 38 39 <sup xmlns:xlink="http://www.w3.org/1999/xlink">/</sup>
###xml 38 39 38 39 <italic xmlns:xlink="http://www.w3.org/1999/xlink"><sup>/</sup></italic>
###xml 39 40 39 40 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 40 51 40 51 <italic xmlns:xlink="http://www.w3.org/1999/xlink">and WT Mice</italic>
###xml 155 160 155 160 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TSG-6</italic>
###xml 160 163 160 163 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 589 590 565 566 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 760 767 736 743 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="tbl1">Table 1</xref>
###xml 799 800 775 776 <italic xmlns:xlink="http://www.w3.org/1999/xlink">b</italic>
###xml 793 800 769 776 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3<italic>b</italic></xref>
###xml 957 962 933 938 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TSG-6</italic>
###xml 962 965 938 941 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 47 51 <span type="species:ncbi:10090">Mice</span>
###xml 164 168 <span type="species:ncbi:10090">mice</span>
###xml 253 257 <span type="species:ncbi:10090">mice</span>
###xml 565 569 <span type="species:ncbi:10090">mice</span>
###xml 966 970 <span type="species:ncbi:10090">mice</span>
Micro-CT Analysis of Bones from TSG-6-/-and WT Mice-Micro-CT was used to determine the histomorphometric parameters of the distal femurs from the knees of TSG-6-/- mice and WT controls (both on a BALB/c background). Preliminary analysis on two pairs of mice indicated that the TSG-6 null animals had approximately twice the bone mass of controls (data not shown). More detailed comparisons on four different pairs confirmed that the percentage trabecular volume (Bv/Tv) of the TSG-6-deficient animals (approximately17%) is significantly greater than that of the WT mice (approximately13%, p = 0.02). TSG-6 knock-out animals also show significant increases in trabecular number (Tb/N) and trabecular thickness (Tb/Th) but not trabecular separation (Tb/Sp) (see Table 1). This is illustrated in Fig. 3b, which compares three-dimensional reconstructions of the trabecular bone network for the TSG-6 null and WT animals. Taken together these findings show that TSG-6-/- mice have increased bone mass compared with wild type littermates, which is contrary to what we had expected based on the effects of TSG-6 on osteoclastic resorption described above and suggests a role for TSG-6 in normal bone homeostasis that might involve modulation of osteoblast differentiation/activity.
###end p 30
###begin p 31
###xml 0 7 0 7 <label xmlns:xlink="http://www.w3.org/1999/xlink">TABLE 1</label>
###xml 85 90 85 90 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TSG-6</italic>
###xml 90 93 90 93 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8211;/&#8211;</sup>
###xml 7 105 7 105 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Histomorphometric parameters for the trabecular regions of distal femurs from <italic>TSG-6</italic><sup>&#8211;/&#8211;</sup> and WT mice</bold>
###xml 7 105 7 105 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="32"><bold>Histomorphometric parameters for the trabecular regions of distal femurs from <italic>TSG-6</italic><sup>&#8211;/&#8211;</sup> and WT mice</bold></p>
###xml 7 105 7 105 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="32"><bold>Histomorphometric parameters for the trabecular regions of distal femurs from <italic>TSG-6</italic><sup>&#8211;/&#8211;</sup> and WT mice</bold></p></caption>
###xml 105 109 105 109 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Mice</bold>
###xml 105 109 105 109 <th xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"><bold>Mice</bold></th>
###xml 109 134 109 134 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Trabecular volume (Bv/Tv)</bold>
###xml 109 134 109 134 <th xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"><bold>Trabecular volume (Bv/Tv)</bold></th>
###xml 134 158 134 158 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Trabecular number (Tb/N)</bold>
###xml 134 158 134 158 <th xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"><bold>Trabecular number (Tb/N)</bold></th>
###xml 158 186 158 186 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Trabecular thickness (Tb/Th)</bold>
###xml 158 186 158 186 <th xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"><bold>Trabecular thickness (Tb/Th)</bold></th>
###xml 186 215 186 215 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Trabecular separation (Tb/Sp)</bold>
###xml 186 215 186 215 <th xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"><bold>Trabecular separation (Tb/Sp)</bold></th>
###xml 105 215 105 215 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><th colspan="1" rowspan="1" align="center" valign="top"><bold>Mice</bold></th><th colspan="1" rowspan="1" align="center" valign="top"><bold>Trabecular volume (Bv/Tv)</bold></th><th colspan="1" rowspan="1" align="center" valign="top"><bold>Trabecular number (Tb/N)</bold></th><th colspan="1" rowspan="1" align="center" valign="top"><bold>Trabecular thickness (Tb/Th)</bold></th><th colspan="1" rowspan="1" align="center" valign="top"><bold>Trabecular separation (Tb/Sp)</bold></th></tr>
###xml 105 215 105 215 <thead xmlns:xlink="http://www.w3.org/1999/xlink"><tr><th colspan="1" rowspan="1" align="center" valign="top"><bold>Mice</bold></th><th colspan="1" rowspan="1" align="center" valign="top"><bold>Trabecular volume (Bv/Tv)</bold></th><th colspan="1" rowspan="1" align="center" valign="top"><bold>Trabecular number (Tb/N)</bold></th><th colspan="1" rowspan="1" align="center" valign="top"><bold>Trabecular thickness (Tb/Th)</bold></th><th colspan="1" rowspan="1" align="center" valign="top"><bold>Trabecular separation (Tb/Sp)</bold></th></tr></thead>
###xml 218 219 218 219 <sup xmlns:xlink="http://www.w3.org/1999/xlink">a</sup>
###xml 218 219 218 219 <italic xmlns:xlink="http://www.w3.org/1999/xlink"><sup>a</sup></italic>
###xml 218 219 218 219 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table-fn" rid="tblfn1"><italic><sup>a</sup></italic></xref>
###xml 215 219 215 219 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="top"> WT<xref ref-type="table-fn" rid="tblfn1"><italic><sup>a</sup></italic></xref></td>
###xml 219 235 219 233 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> 12.8 (&#177;0.81) </td>
###xml 235 251 233 247 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> 2.23 (&#177;0.13) </td>
###xml 251 269 247 263 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> 0.057 (&#177;0.001) </td>
###xml 269 287 263 279 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> 0.288 (&#177;0.019) </td>
###xml 215 287 215 279 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td colspan="1" rowspan="1" align="left" valign="top"> WT<xref ref-type="table-fn" rid="tblfn1"><italic><sup>a</sup></italic></xref></td><td colspan="1" rowspan="1" align="center" valign="top"> 12.8 (&#177;0.81) </td><td colspan="1" rowspan="1" align="center" valign="top"> 2.23 (&#177;0.13) </td><td colspan="1" rowspan="1" align="center" valign="top"> 0.057 (&#177;0.001) </td><td colspan="1" rowspan="1" align="center" valign="top"> 0.288 (&#177;0.019) </td></tr>
###xml 287 292 279 284 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TSG-6</italic>
###xml 292 295 284 287 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8211;/&#8211;</sup>
###xml 295 296 287 288 <sup xmlns:xlink="http://www.w3.org/1999/xlink">a</sup>
###xml 295 296 287 288 <italic xmlns:xlink="http://www.w3.org/1999/xlink"><sup>a</sup></italic>
###xml 295 296 287 288 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table-fn" rid="tblfn1"><italic><sup>a</sup></italic></xref>
###xml 287 296 279 288 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="top"><italic>TSG-6</italic><sup>&#8211;/&#8211;</sup><xref ref-type="table-fn" rid="tblfn1"><italic><sup>a</sup></italic></xref></td>
###xml 311 312 301 302 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b</sup>
###xml 311 312 301 302 <italic xmlns:xlink="http://www.w3.org/1999/xlink"><sup>b</sup></italic>
###xml 311 312 301 302 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table-fn" rid="tblfn2"><italic><sup>b</sup></italic></xref>
###xml 296 312 288 302 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> 17.0 (&#177;0.42)<xref ref-type="table-fn" rid="tblfn2"><italic><sup>b</sup></italic></xref></td>
###xml 327 328 315 316 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b</sup>
###xml 327 328 315 316 <italic xmlns:xlink="http://www.w3.org/1999/xlink"><sup>b</sup></italic>
###xml 327 328 315 316 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table-fn" rid="tblfn2"><italic><sup>b</sup></italic></xref>
###xml 312 328 302 316 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> 2.66 (&#177;0.04)<xref ref-type="table-fn" rid="tblfn2"><italic><sup>b</sup></italic></xref></td>
###xml 345 346 331 332 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b</sup>
###xml 345 346 331 332 <italic xmlns:xlink="http://www.w3.org/1999/xlink"><sup>b</sup></italic>
###xml 345 346 331 332 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table-fn" rid="tblfn2"><italic><sup>b</sup></italic></xref>
###xml 328 346 316 332 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> 0.064 (&#177;0.002)<xref ref-type="table-fn" rid="tblfn2"><italic><sup>b</sup></italic></xref></td>
###xml 346 364 332 348 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> 0.256 (&#177;0.012) </td>
###xml 287 364 279 348 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td colspan="1" rowspan="1" align="left" valign="top"><italic>TSG-6</italic><sup>&#8211;/&#8211;</sup><xref ref-type="table-fn" rid="tblfn1"><italic><sup>a</sup></italic></xref></td><td colspan="1" rowspan="1" align="center" valign="top"> 17.0 (&#177;0.42)<xref ref-type="table-fn" rid="tblfn2"><italic><sup>b</sup></italic></xref></td><td colspan="1" rowspan="1" align="center" valign="top"> 2.66 (&#177;0.04)<xref ref-type="table-fn" rid="tblfn2"><italic><sup>b</sup></italic></xref></td><td colspan="1" rowspan="1" align="center" valign="top"> 0.064 (&#177;0.002)<xref ref-type="table-fn" rid="tblfn2"><italic><sup>b</sup></italic></xref></td><td colspan="1" rowspan="1" align="center" valign="top"> 0.256 (&#177;0.012) </td></tr>
###xml 215 364 215 348 <tbody xmlns:xlink="http://www.w3.org/1999/xlink"><tr><td colspan="1" rowspan="1" align="left" valign="top"> WT<xref ref-type="table-fn" rid="tblfn1"><italic><sup>a</sup></italic></xref></td><td colspan="1" rowspan="1" align="center" valign="top"> 12.8 (&#177;0.81) </td><td colspan="1" rowspan="1" align="center" valign="top"> 2.23 (&#177;0.13) </td><td colspan="1" rowspan="1" align="center" valign="top"> 0.057 (&#177;0.001) </td><td colspan="1" rowspan="1" align="center" valign="top"> 0.288 (&#177;0.019) </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"><italic>TSG-6</italic><sup>&#8211;/&#8211;</sup><xref ref-type="table-fn" rid="tblfn1"><italic><sup>a</sup></italic></xref></td><td colspan="1" rowspan="1" align="center" valign="top"> 17.0 (&#177;0.42)<xref ref-type="table-fn" rid="tblfn2"><italic><sup>b</sup></italic></xref></td><td colspan="1" rowspan="1" align="center" valign="top"> 2.66 (&#177;0.04)<xref ref-type="table-fn" rid="tblfn2"><italic><sup>b</sup></italic></xref></td><td colspan="1" rowspan="1" align="center" valign="top"> 0.064 (&#177;0.002)<xref ref-type="table-fn" rid="tblfn2"><italic><sup>b</sup></italic></xref></td><td colspan="1" rowspan="1" align="center" valign="top"> 0.256 (&#177;0.012) </td></tr></tbody>
###xml 105 364 105 348 <table xmlns:xlink="http://www.w3.org/1999/xlink" frame="hsides" rules="groups"><thead><tr><th colspan="1" rowspan="1" align="center" valign="top"><bold>Mice</bold></th><th colspan="1" rowspan="1" align="center" valign="top"><bold>Trabecular volume (Bv/Tv)</bold></th><th colspan="1" rowspan="1" align="center" valign="top"><bold>Trabecular number (Tb/N)</bold></th><th colspan="1" rowspan="1" align="center" valign="top"><bold>Trabecular thickness (Tb/Th)</bold></th><th colspan="1" rowspan="1" align="center" valign="top"><bold>Trabecular separation (Tb/Sp)</bold></th></tr></thead><tbody><tr><td colspan="1" rowspan="1" align="left" valign="top"> WT<xref ref-type="table-fn" rid="tblfn1"><italic><sup>a</sup></italic></xref></td><td colspan="1" rowspan="1" align="center" valign="top"> 12.8 (&#177;0.81) </td><td colspan="1" rowspan="1" align="center" valign="top"> 2.23 (&#177;0.13) </td><td colspan="1" rowspan="1" align="center" valign="top"> 0.057 (&#177;0.001) </td><td colspan="1" rowspan="1" align="center" valign="top"> 0.288 (&#177;0.019) </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"><italic>TSG-6</italic><sup>&#8211;/&#8211;</sup><xref ref-type="table-fn" rid="tblfn1"><italic><sup>a</sup></italic></xref></td><td colspan="1" rowspan="1" align="center" valign="top"> 17.0 (&#177;0.42)<xref ref-type="table-fn" rid="tblfn2"><italic><sup>b</sup></italic></xref></td><td colspan="1" rowspan="1" align="center" valign="top"> 2.66 (&#177;0.04)<xref ref-type="table-fn" rid="tblfn2"><italic><sup>b</sup></italic></xref></td><td colspan="1" rowspan="1" align="center" valign="top"> 0.064 (&#177;0.002)<xref ref-type="table-fn" rid="tblfn2"><italic><sup>b</sup></italic></xref></td><td colspan="1" rowspan="1" align="center" valign="top"> 0.256 (&#177;0.012) </td></tr></tbody></table>
###xml 364 365 348 349 <label xmlns:xlink="http://www.w3.org/1999/xlink">a</label>
###xml 387 388 371 372 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 365 402 349 384 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="33">Average values shown (<italic>n</italic> = 4 &#177; S.E.)</p>
###xml 364 402 348 384 <fn xmlns:xlink="http://www.w3.org/1999/xlink" id="tblfn1"><label>a</label><p textid="33">Average values shown (<italic>n</italic> = 4 &#177; S.E.)</p></fn>
###xml 402 403 384 385 <label xmlns:xlink="http://www.w3.org/1999/xlink">b</label>
###xml 518 519 500 501 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 403 529 385 509 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="34">Mean values were compared using a non-parametrical Kruskall-Wallis test and found to differ significantly from WT (<italic>p</italic> &#8804; 0.02)</p>
###xml 402 529 384 509 <fn xmlns:xlink="http://www.w3.org/1999/xlink" id="tblfn2"><label>b</label><p textid="34">Mean values were compared using a non-parametrical Kruskall-Wallis test and found to differ significantly from WT (<italic>p</italic> &#8804; 0.02)</p></fn>
###xml 364 529 348 509 <table-wrap-foot xmlns:xlink="http://www.w3.org/1999/xlink"><fn id="tblfn1"><label>a</label><p textid="33">Average values shown (<italic>n</italic> = 4 &#177; S.E.)</p></fn><fn id="tblfn2"><label>b</label><p textid="34">Mean values were compared using a non-parametrical Kruskall-Wallis test and found to differ significantly from WT (<italic>p</italic> &#8804; 0.02)</p></fn></table-wrap-foot>
###xml 0 529 0 509 <table-wrap xmlns:xlink="http://www.w3.org/1999/xlink" position="float" id="tbl1"><label>TABLE 1</label><caption><p textid="32"><bold>Histomorphometric parameters for the trabecular regions of distal femurs from <italic>TSG-6</italic><sup>&#8211;/&#8211;</sup> and WT mice</bold></p></caption><table frame="hsides" rules="groups"><thead><tr><th colspan="1" rowspan="1" align="center" valign="top"><bold>Mice</bold></th><th colspan="1" rowspan="1" align="center" valign="top"><bold>Trabecular volume (Bv/Tv)</bold></th><th colspan="1" rowspan="1" align="center" valign="top"><bold>Trabecular number (Tb/N)</bold></th><th colspan="1" rowspan="1" align="center" valign="top"><bold>Trabecular thickness (Tb/Th)</bold></th><th colspan="1" rowspan="1" align="center" valign="top"><bold>Trabecular separation (Tb/Sp)</bold></th></tr></thead><tbody><tr><td colspan="1" rowspan="1" align="left" valign="top"> WT<xref ref-type="table-fn" rid="tblfn1"><italic><sup>a</sup></italic></xref></td><td colspan="1" rowspan="1" align="center" valign="top"> 12.8 (&#177;0.81) </td><td colspan="1" rowspan="1" align="center" valign="top"> 2.23 (&#177;0.13) </td><td colspan="1" rowspan="1" align="center" valign="top"> 0.057 (&#177;0.001) </td><td colspan="1" rowspan="1" align="center" valign="top"> 0.288 (&#177;0.019) </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"><italic>TSG-6</italic><sup>&#8211;/&#8211;</sup><xref ref-type="table-fn" rid="tblfn1"><italic><sup>a</sup></italic></xref></td><td colspan="1" rowspan="1" align="center" valign="top"> 17.0 (&#177;0.42)<xref ref-type="table-fn" rid="tblfn2"><italic><sup>b</sup></italic></xref></td><td colspan="1" rowspan="1" align="center" valign="top"> 2.66 (&#177;0.04)<xref ref-type="table-fn" rid="tblfn2"><italic><sup>b</sup></italic></xref></td><td colspan="1" rowspan="1" align="center" valign="top"> 0.064 (&#177;0.002)<xref ref-type="table-fn" rid="tblfn2"><italic><sup>b</sup></italic></xref></td><td colspan="1" rowspan="1" align="center" valign="top"> 0.256 (&#177;0.012) </td></tr></tbody></table><table-wrap-foot><fn id="tblfn1"><label>a</label><p textid="33">Average values shown (<italic>n</italic> = 4 &#177; S.E.)</p></fn><fn id="tblfn2"><label>b</label><p textid="34">Mean values were compared using a non-parametrical Kruskall-Wallis test and found to differ significantly from WT (<italic>p</italic> &#8804; 0.02)</p></fn></table-wrap-foot></table-wrap>
TABLE 1Histomorphometric parameters for the trabecular regions of distal femurs from TSG-6-/- and WT miceMiceTrabecular volume (Bv/Tv)Trabecular number (Tb/N)Trabecular thickness (Tb/Th)Trabecular separation (Tb/Sp) WTa 12.8 (+/-0.81)  2.23 (+/-0.13)  0.057 (+/-0.001)  0.288 (+/-0.019) TSG-6-/-a 17.0 (+/-0.42)b 2.66 (+/-0.04)b 0.064 (+/-0.002)b 0.256 (+/-0.012) aAverage values shown (n = 4 +/- S.E.)bMean values were compared using a non-parametrical Kruskall-Wallis test and found to differ significantly from WT (p </= 0.02)
###end p 31
###begin p 32
###xml 78 83 78 83 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TSG-6</italic>
###xml 83 86 83 86 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8211;/&#8211;</sup>
###xml 0 98 0 98 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Histomorphometric parameters for the trabecular regions of distal femurs from <italic>TSG-6</italic><sup>&#8211;/&#8211;</sup> and WT mice</bold>
###xml 94 98 <span type="species:ncbi:10090">mice</span>
Histomorphometric parameters for the trabecular regions of distal femurs from TSG-6-/- and WT mice
###end p 32
###begin p 33
###xml 22 23 22 23 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
Average values shown (n = 4 +/- S.E.)
###end p 33
###begin p 34
###xml 115 116 115 116 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
Mean values were compared using a non-parametrical Kruskall-Wallis test and found to differ significantly from WT (p </= 0.02)
###end p 34
###begin p 35
###xml 0 58 0 58 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Immunolocalization of TSG-6 in Wild Type Mouse Knee Joints</italic>
###xml 113 119 113 119 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4</xref>
###xml 262 270 262 270 <italic xmlns:xlink="http://www.w3.org/1999/xlink">panels i</italic>
###xml 275 277 275 277 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ii</italic>
###xml 357 365 357 365 <italic xmlns:xlink="http://www.w3.org/1999/xlink">panel ii</italic>
###xml 411 419 411 419 <italic xmlns:xlink="http://www.w3.org/1999/xlink">panel iv</italic>
###xml 552 561 552 561 <italic xmlns:xlink="http://www.w3.org/1999/xlink">panels iv</italic>
###xml 566 567 566 567 <italic xmlns:xlink="http://www.w3.org/1999/xlink">v</italic>
###xml 713 730 713 730 <italic xmlns:xlink="http://www.w3.org/1999/xlink">panels i, ii, iii</italic>
###xml 736 737 736 737 <italic xmlns:xlink="http://www.w3.org/1999/xlink">v</italic>
###xml 890 899 890 899 <italic xmlns:xlink="http://www.w3.org/1999/xlink">asterisks</italic>
###xml 903 912 903 912 <italic xmlns:xlink="http://www.w3.org/1999/xlink">panels ii</italic>
###xml 917 920 917 920 <italic xmlns:xlink="http://www.w3.org/1999/xlink">iii</italic>
###xml 41 46 <span type="species:ncbi:10090">Mouse</span>
###xml 93 99 <span type="species:ncbi:10090">murine</span>
Immunolocalization of TSG-6 in Wild Type Mouse Knee Joints-Immunohistochemistry of wild type murine knee joints (Fig. 4) with anti-TSG-6 antibody showed immunoreactive TSG-6 to be associated with cells in the superficial and midzones of the articular cartilage (panels i and ii) and the lower region of hypertropic cartilage in the epiphyseal growth plate (panel ii) as well as with meniscal fibrochondrocytes (panel iv). In the synovium and periosteum only a few positively stained cells were detected, where these have a flattened or fusiform shape (panels iv and v). Notably, the strongest immunostaining was associated with the cells in the epiphyseal and metaphyseal bone marrow of both the femur and tibia (panels i, ii, iii, and v), at the margins of bone marrow and trabecular bone, and in the extracellular matrix of calcified cartilage adjoining the trabecular bone (indicated by asterisks in panels ii and iii).
###end p 35
###begin p 36
###xml 0 9 0 9 <label xmlns:xlink="http://www.w3.org/1999/xlink">FIGURE 3.</label>
###xml 9 14 9 14 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TSG-6</italic>
###xml 14 17 14 17 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 9 159 9 159 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>TSG-6</italic><sup>-/-</sup> mice exhibit elevated osteoclast resorptive activity in response to RANKL/M-CSF but greater trabecular bone mass in the absence of challenge.</bold>
###xml 159 160 159 160 <italic xmlns:xlink="http://www.w3.org/1999/xlink">a</italic>
###xml 213 218 213 218 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TSG-6</italic>
###xml 218 221 218 221 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 244 246 244 246 <italic xmlns:xlink="http://www.w3.org/1999/xlink">WT</italic>
###xml 301 306 301 306 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Media</italic>
###xml 458 459 458 459 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 482 492 480 490 <italic xmlns:xlink="http://www.w3.org/1999/xlink">black bars</italic>
###xml 498 503 496 501 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TSG-6</italic>
###xml 503 506 501 504 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 508 517 506 515 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gray bars</italic>
###xml 609 614 607 612 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TSG-6</italic>
###xml 614 617 612 615 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 644 645 642 643 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 694 695 692 693 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 737 738 735 736 <italic xmlns:xlink="http://www.w3.org/1999/xlink">b</italic>
###xml 865 876 863 874 <italic xmlns:xlink="http://www.w3.org/1999/xlink">upper panel</italic>
###xml 882 887 880 885 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TSG-6</italic>
###xml 887 890 885 888 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 892 903 890 901 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lower panel</italic>
###xml 9 990 9 988 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="37"><bold><italic>TSG-6</italic><sup>-/-</sup> mice exhibit elevated osteoclast resorptive activity in response to RANKL/M-CSF but greater trabecular bone mass in the absence of challenge.</bold><italic>a</italic>, osteoclast precursors from the long bone marrow of <italic>TSG-6</italic><sup>-/-</sup> and wild type BALB/c (<italic>WT</italic>) mice were cultured on dentine slices in the absence (<italic>Media</italic>) or presence of M-CSF and/or murine sRANKL for 10 days before the determination of lacunar resorption. Data are plotted as mean percentage resorption (<italic>n</italic> = 4) &#177; S.E. for WT (<italic>black bars</italic>) and <italic>TSG-6</italic><sup>-/-</sup> (<italic>gray bars</italic>) mice. Lacunar resorption was significantly greater in the presence of cells isolated from <italic>TSG-6</italic><sup>-/-</sup> mice as compared with WT; <italic>p</italic> = 0.03 for cultures containing sRANKL alone and <italic>p</italic> = 0.004 for those with M-CSF and sRANKL. <italic>b</italic>, three-dimensional models of the trabecular bone were generated after micro-CT scanning of the hind limb distal femurs of WT (<italic>upper panel</italic>) and <italic>TSG-6</italic><sup>-/-</sup> (<italic>lower panel</italic>) male mice. Four mice were analyzed in each case, and representative models are shown.</p>
###xml 9 990 9 988 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="37"><bold><italic>TSG-6</italic><sup>-/-</sup> mice exhibit elevated osteoclast resorptive activity in response to RANKL/M-CSF but greater trabecular bone mass in the absence of challenge.</bold><italic>a</italic>, osteoclast precursors from the long bone marrow of <italic>TSG-6</italic><sup>-/-</sup> and wild type BALB/c (<italic>WT</italic>) mice were cultured on dentine slices in the absence (<italic>Media</italic>) or presence of M-CSF and/or murine sRANKL for 10 days before the determination of lacunar resorption. Data are plotted as mean percentage resorption (<italic>n</italic> = 4) &#177; S.E. for WT (<italic>black bars</italic>) and <italic>TSG-6</italic><sup>-/-</sup> (<italic>gray bars</italic>) mice. Lacunar resorption was significantly greater in the presence of cells isolated from <italic>TSG-6</italic><sup>-/-</sup> mice as compared with WT; <italic>p</italic> = 0.03 for cultures containing sRANKL alone and <italic>p</italic> = 0.004 for those with M-CSF and sRANKL. <italic>b</italic>, three-dimensional models of the trabecular bone were generated after micro-CT scanning of the hind limb distal femurs of WT (<italic>upper panel</italic>) and <italic>TSG-6</italic><sup>-/-</sup> (<italic>lower panel</italic>) male mice. Four mice were analyzed in each case, and representative models are shown.</p></caption>
###xml 990 990 988 988 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="zbc0370847930003"/>
###xml 0 990 0 988 <fig xmlns:xlink="http://www.w3.org/1999/xlink" position="float" id="fig3"><label>FIGURE 3.</label><caption><p textid="37"><bold><italic>TSG-6</italic><sup>-/-</sup> mice exhibit elevated osteoclast resorptive activity in response to RANKL/M-CSF but greater trabecular bone mass in the absence of challenge.</bold><italic>a</italic>, osteoclast precursors from the long bone marrow of <italic>TSG-6</italic><sup>-/-</sup> and wild type BALB/c (<italic>WT</italic>) mice were cultured on dentine slices in the absence (<italic>Media</italic>) or presence of M-CSF and/or murine sRANKL for 10 days before the determination of lacunar resorption. Data are plotted as mean percentage resorption (<italic>n</italic> = 4) &#177; S.E. for WT (<italic>black bars</italic>) and <italic>TSG-6</italic><sup>-/-</sup> (<italic>gray bars</italic>) mice. Lacunar resorption was significantly greater in the presence of cells isolated from <italic>TSG-6</italic><sup>-/-</sup> mice as compared with WT; <italic>p</italic> = 0.03 for cultures containing sRANKL alone and <italic>p</italic> = 0.004 for those with M-CSF and sRANKL. <italic>b</italic>, three-dimensional models of the trabecular bone were generated after micro-CT scanning of the hind limb distal femurs of WT (<italic>upper panel</italic>) and <italic>TSG-6</italic><sup>-/-</sup> (<italic>lower panel</italic>) male mice. Four mice were analyzed in each case, and representative models are shown.</p></caption><graphic xlink:href="zbc0370847930003"/></fig>
###xml 18 22 <span type="species:ncbi:10090">mice</span>
###xml 248 252 <span type="species:ncbi:10090">mice</span>
###xml 336 342 <span type="species:ncbi:10090">murine</span>
###xml 519 523 <span type="species:ncbi:10090">mice</span>
###xml 618 622 <span type="species:ncbi:10090">mice</span>
###xml 910 914 <span type="species:ncbi:10090">mice</span>
###xml 921 925 <span type="species:ncbi:10090">mice</span>
FIGURE 3.TSG-6-/- mice exhibit elevated osteoclast resorptive activity in response to RANKL/M-CSF but greater trabecular bone mass in the absence of challenge.a, osteoclast precursors from the long bone marrow of TSG-6-/- and wild type BALB/c (WT) mice were cultured on dentine slices in the absence (Media) or presence of M-CSF and/or murine sRANKL for 10 days before the determination of lacunar resorption. Data are plotted as mean percentage resorption (n = 4) +/- S.E. for WT (black bars) and TSG-6-/- (gray bars) mice. Lacunar resorption was significantly greater in the presence of cells isolated from TSG-6-/- mice as compared with WT; p = 0.03 for cultures containing sRANKL alone and p = 0.004 for those with M-CSF and sRANKL. b, three-dimensional models of the trabecular bone were generated after micro-CT scanning of the hind limb distal femurs of WT (upper panel) and TSG-6-/- (lower panel) male mice. Four mice were analyzed in each case, and representative models are shown.
###end p 36
###begin p 37
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TSG-6</italic>
###xml 5 8 5 8 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 0 150 0 150 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>TSG-6</italic><sup>-/-</sup> mice exhibit elevated osteoclast resorptive activity in response to RANKL/M-CSF but greater trabecular bone mass in the absence of challenge.</bold>
###xml 150 151 150 151 <italic xmlns:xlink="http://www.w3.org/1999/xlink">a</italic>
###xml 204 209 204 209 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TSG-6</italic>
###xml 209 212 209 212 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 235 237 235 237 <italic xmlns:xlink="http://www.w3.org/1999/xlink">WT</italic>
###xml 292 297 292 297 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Media</italic>
###xml 449 450 449 450 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 473 483 471 481 <italic xmlns:xlink="http://www.w3.org/1999/xlink">black bars</italic>
###xml 489 494 487 492 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TSG-6</italic>
###xml 494 497 492 495 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 499 508 497 506 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gray bars</italic>
###xml 600 605 598 603 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TSG-6</italic>
###xml 605 608 603 606 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 635 636 633 634 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 685 686 683 684 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 728 729 726 727 <italic xmlns:xlink="http://www.w3.org/1999/xlink">b</italic>
###xml 856 867 854 865 <italic xmlns:xlink="http://www.w3.org/1999/xlink">upper panel</italic>
###xml 873 878 871 876 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TSG-6</italic>
###xml 878 881 876 879 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 883 894 881 892 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lower panel</italic>
###xml 9 13 <span type="species:ncbi:10090">mice</span>
###xml 239 243 <span type="species:ncbi:10090">mice</span>
###xml 327 333 <span type="species:ncbi:10090">murine</span>
###xml 510 514 <span type="species:ncbi:10090">mice</span>
###xml 609 613 <span type="species:ncbi:10090">mice</span>
###xml 901 905 <span type="species:ncbi:10090">mice</span>
###xml 912 916 <span type="species:ncbi:10090">mice</span>
TSG-6-/- mice exhibit elevated osteoclast resorptive activity in response to RANKL/M-CSF but greater trabecular bone mass in the absence of challenge.a, osteoclast precursors from the long bone marrow of TSG-6-/- and wild type BALB/c (WT) mice were cultured on dentine slices in the absence (Media) or presence of M-CSF and/or murine sRANKL for 10 days before the determination of lacunar resorption. Data are plotted as mean percentage resorption (n = 4) +/- S.E. for WT (black bars) and TSG-6-/- (gray bars) mice. Lacunar resorption was significantly greater in the presence of cells isolated from TSG-6-/- mice as compared with WT; p = 0.03 for cultures containing sRANKL alone and p = 0.004 for those with M-CSF and sRANKL. b, three-dimensional models of the trabecular bone were generated after micro-CT scanning of the hind limb distal femurs of WT (upper panel) and TSG-6-/- (lower panel) male mice. Four mice were analyzed in each case, and representative models are shown.
###end p 37
###begin p 38
###xml 0 9 0 9 <label xmlns:xlink="http://www.w3.org/1999/xlink">FIGURE 4.</label>
###xml 9 65 9 65 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Immunolocalization of TSG-6 in normal mouse knee joints.</bold>
###xml 184 192 184 192 <italic xmlns:xlink="http://www.w3.org/1999/xlink">panels i</italic>
###xml 197 199 197 199 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ii</italic>
###xml 201 211 201 211 <italic xmlns:xlink="http://www.w3.org/1999/xlink">scale bars</italic>
###xml 232 245 231 244 <italic xmlns:xlink="http://www.w3.org/1999/xlink">panels ii, iv</italic>
###xml 251 252 250 251 <italic xmlns:xlink="http://www.w3.org/1999/xlink">v</italic>
###xml 254 264 253 263 <italic xmlns:xlink="http://www.w3.org/1999/xlink">scale bars</italic>
###xml 327 330 325 328 <italic xmlns:xlink="http://www.w3.org/1999/xlink">red</italic>
###xml 338 343 336 341 <italic xmlns:xlink="http://www.w3.org/1999/xlink">green</italic>
###xml 359 363 357 361 <italic xmlns:xlink="http://www.w3.org/1999/xlink">blue</italic>
###xml 378 380 376 378 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BM</italic>
###xml 395 398 393 396 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FCC</italic>
###xml 427 429 425 427 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GP</italic>
###xml 466 469 464 467 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MEN</italic>
###xml 481 483 479 481 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PO</italic>
###xml 497 500 495 498 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SCB</italic>
###xml 519 522 517 520 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SYN</italic>
###xml 534 537 532 535 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TPC</italic>
###xml 565 567 563 565 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CL</italic>
###xml 9 587 9 585 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="39"><bold>Immunolocalization of TSG-6 in normal mouse knee joints.</bold> Sections were immunostained for TSG-6 and HA, as described under &#8220;Experimental Procedures.&#8221; Images were taken at 10&#215; (<italic>panels i</italic> and <italic>ii</italic>; <italic>scale bars</italic> = 400 &#956;m) and 63&#215; (<italic>panels ii, iv</italic>, and <italic>v</italic>; <italic>scale bars</italic> = 100 &#956;m) magnifications. TSG-6 immunoreactivity is shown as <italic>red</italic>, HA as <italic>green</italic>, and nuclei as <italic>blue</italic> fluorescence. <italic>BM</italic>, bone marrow; <italic>FCC</italic>, femoral condyle cartilage; <italic>GP</italic>, epiphyseal growth plate cartilage; <italic>MEN</italic>, meniscus; <italic>PO</italic>, periosteum; <italic>SCB</italic>, subcondral bone; <italic>SYN</italic>, synovium; <italic>TPC</italic>, tibial plateau cartilage; <italic>CL</italic>, cruciate ligament.</p>
###xml 9 587 9 585 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="39"><bold>Immunolocalization of TSG-6 in normal mouse knee joints.</bold> Sections were immunostained for TSG-6 and HA, as described under &#8220;Experimental Procedures.&#8221; Images were taken at 10&#215; (<italic>panels i</italic> and <italic>ii</italic>; <italic>scale bars</italic> = 400 &#956;m) and 63&#215; (<italic>panels ii, iv</italic>, and <italic>v</italic>; <italic>scale bars</italic> = 100 &#956;m) magnifications. TSG-6 immunoreactivity is shown as <italic>red</italic>, HA as <italic>green</italic>, and nuclei as <italic>blue</italic> fluorescence. <italic>BM</italic>, bone marrow; <italic>FCC</italic>, femoral condyle cartilage; <italic>GP</italic>, epiphyseal growth plate cartilage; <italic>MEN</italic>, meniscus; <italic>PO</italic>, periosteum; <italic>SCB</italic>, subcondral bone; <italic>SYN</italic>, synovium; <italic>TPC</italic>, tibial plateau cartilage; <italic>CL</italic>, cruciate ligament.</p></caption>
###xml 587 587 585 585 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="zbc0370847930004"/>
###xml 0 587 0 585 <fig xmlns:xlink="http://www.w3.org/1999/xlink" position="float" id="fig4"><label>FIGURE 4.</label><caption><p textid="39"><bold>Immunolocalization of TSG-6 in normal mouse knee joints.</bold> Sections were immunostained for TSG-6 and HA, as described under &#8220;Experimental Procedures.&#8221; Images were taken at 10&#215; (<italic>panels i</italic> and <italic>ii</italic>; <italic>scale bars</italic> = 400 &#956;m) and 63&#215; (<italic>panels ii, iv</italic>, and <italic>v</italic>; <italic>scale bars</italic> = 100 &#956;m) magnifications. TSG-6 immunoreactivity is shown as <italic>red</italic>, HA as <italic>green</italic>, and nuclei as <italic>blue</italic> fluorescence. <italic>BM</italic>, bone marrow; <italic>FCC</italic>, femoral condyle cartilage; <italic>GP</italic>, epiphyseal growth plate cartilage; <italic>MEN</italic>, meniscus; <italic>PO</italic>, periosteum; <italic>SCB</italic>, subcondral bone; <italic>SYN</italic>, synovium; <italic>TPC</italic>, tibial plateau cartilage; <italic>CL</italic>, cruciate ligament.</p></caption><graphic xlink:href="zbc0370847930004"/></fig>
###xml 47 52 <span type="species:ncbi:10090">mouse</span>
FIGURE 4.Immunolocalization of TSG-6 in normal mouse knee joints. Sections were immunostained for TSG-6 and HA, as described under "Experimental Procedures." Images were taken at 10x (panels i and ii; scale bars = 400 mum) and 63x (panels ii, iv, and v; scale bars = 100 mum) magnifications. TSG-6 immunoreactivity is shown as red, HA as green, and nuclei as blue fluorescence. BM, bone marrow; FCC, femoral condyle cartilage; GP, epiphyseal growth plate cartilage; MEN, meniscus; PO, periosteum; SCB, subcondral bone; SYN, synovium; TPC, tibial plateau cartilage; CL, cruciate ligament.
###end p 38
###begin p 39
###xml 0 56 0 56 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Immunolocalization of TSG-6 in normal mouse knee joints.</bold>
###xml 175 183 175 183 <italic xmlns:xlink="http://www.w3.org/1999/xlink">panels i</italic>
###xml 188 190 188 190 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ii</italic>
###xml 192 202 192 202 <italic xmlns:xlink="http://www.w3.org/1999/xlink">scale bars</italic>
###xml 223 236 222 235 <italic xmlns:xlink="http://www.w3.org/1999/xlink">panels ii, iv</italic>
###xml 242 243 241 242 <italic xmlns:xlink="http://www.w3.org/1999/xlink">v</italic>
###xml 245 255 244 254 <italic xmlns:xlink="http://www.w3.org/1999/xlink">scale bars</italic>
###xml 318 321 316 319 <italic xmlns:xlink="http://www.w3.org/1999/xlink">red</italic>
###xml 329 334 327 332 <italic xmlns:xlink="http://www.w3.org/1999/xlink">green</italic>
###xml 350 354 348 352 <italic xmlns:xlink="http://www.w3.org/1999/xlink">blue</italic>
###xml 369 371 367 369 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BM</italic>
###xml 386 389 384 387 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FCC</italic>
###xml 418 420 416 418 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GP</italic>
###xml 457 460 455 458 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MEN</italic>
###xml 472 474 470 472 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PO</italic>
###xml 488 491 486 489 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SCB</italic>
###xml 510 513 508 511 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SYN</italic>
###xml 525 528 523 526 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TPC</italic>
###xml 556 558 554 556 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CL</italic>
###xml 38 43 <span type="species:ncbi:10090">mouse</span>
Immunolocalization of TSG-6 in normal mouse knee joints. Sections were immunostained for TSG-6 and HA, as described under "Experimental Procedures." Images were taken at 10x (panels i and ii; scale bars = 400 mum) and 63x (panels ii, iv, and v; scale bars = 100 mum) magnifications. TSG-6 immunoreactivity is shown as red, HA as green, and nuclei as blue fluorescence. BM, bone marrow; FCC, femoral condyle cartilage; GP, epiphyseal growth plate cartilage; MEN, meniscus; PO, periosteum; SCB, subcondral bone; SYN, synovium; TPC, tibial plateau cartilage; CL, cruciate ligament.
###end p 39
###begin p 40
###xml 0 59 0 59 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Effect of TSG-6 on BMP-2-induced Osteoblast Differentiation</italic>
###xml 151 153 151 153 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref50">50</xref>
###xml 196 200 196 200 <italic xmlns:xlink="http://www.w3.org/1999/xlink">i.e.</italic>
###xml 231 232 231 232 <italic xmlns:xlink="http://www.w3.org/1999/xlink">a</italic>
###xml 225 232 225 232 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">Fig. 5<italic>a</italic></xref>
###xml 277 278 277 278 <italic xmlns:xlink="http://www.w3.org/1999/xlink">b</italic>
###xml 271 278 271 278 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">Fig. 5<italic>b</italic></xref>
###xml 529 530 529 530 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 694 700 694 700 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">Fig. 5</xref>
###xml 162 168 <span type="species:ncbi:10090">murine</span>
Effect of TSG-6 on BMP-2-induced Osteoblast Differentiation-As a model of BMP-2-induced osteoblast differentiation, we measured the production of ALP (50) by two murine pre-osteogenic cell lines (i.e. stromal MBA-15.4 cells (Fig. 5a) and calvaria-derived MC3T3.E1 cells (Fig. 5b)) cultured in the presence of BMP-2 with and without the addition of TSG-6 proteins. The full-length protein caused a dose-dependent reduction in BMP-2-induced ALP activity, with essentially complete inhibition of differentiation seen at 33 and 6.6 nm TSG-6 for the MBA-15.4 and MC3T3.E1 cell lines, respectively. In contrast, neither Link_TSG6 nor CUB_C_TSG6 had significant effects on ALP release by these cells (Fig. 5).
###end p 40
###begin p 41
###xml 0 42 0 42 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Interactions of TSG-6 with BMPs and sRANKL</italic>
###xml 145 151 145 151 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig6" ref-type="fig">Fig. 6</xref>
###xml 397 401 397 401 <italic xmlns:xlink="http://www.w3.org/1999/xlink">i.e.</italic>
###xml 458 464 458 464 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig7" ref-type="fig">Fig. 7</xref>
###xml 831 832 818 819 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 834 841 821 828 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="tbl2">Table 2</xref>
Interactions of TSG-6 with BMPs and sRANKL-The interactions of TSG-6 with BMP-2 and other BMPs were investigated using ELISAs. As illustrated in Fig. 6, BMP-2 and the structurally and functionally related BMP-4, -5, -6, -7, -13, and -14 all interact with TSG-6, whereas there is no apparent binding to the more distantly related BMP-3. Further analysis of BMP-2 and two other representative BMPs (i.e. BMP-13 and -14) revealed that Link_TSG6 and CUB_C_TSG6 (Fig. 7) have a lower level of binding to these immobilized proteins compared with full-length TSG-6. Surface plasmon resonance experiments, where TSG-6 or its individual domains were flowed over BMP-coupled chips, allowed determination of the affinities for these interactions. The dissociation constants for TSG-6 binding to BMP-2, -13, and -14 are all approximately0.2 mum (Table 2). In the case of BMP-2, its interactions with the Link module and CUB_C domain are both approximately11-fold weaker, suggesting that BMP-2 interacts with a composite binding surface on TSG-6 that involves both these domains. Similarly, BMP-13 and -14 have lower affinities for the isolated domains of TSG-6 compared with the full-length protein. However, these BMPs both bind more strongly to the Link module than the CUB_C domain, perhaps indicating that the Link module makes a greater contribution to the interaction surfaces in these cases.
###end p 41
###begin p 42
###xml 0 7 0 7 <label xmlns:xlink="http://www.w3.org/1999/xlink">TABLE 2</label>
###xml 7 146 7 146 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Dissociation constants for the interactions of TSG-6 and its isolated domains with BMPs and sRANKL, determined by surface plasmon resonance</bold>
###xml 7 146 7 146 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="43"><bold>Dissociation constants for the interactions of TSG-6 and its isolated domains with BMPs and sRANKL, determined by surface plasmon resonance</bold></p>
###xml 7 146 7 146 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="43"><bold>Dissociation constants for the interactions of TSG-6 and its isolated domains with BMPs and sRANKL, determined by surface plasmon resonance</bold></p></caption>
###xml 146 153 146 153 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Protein</bold>
###xml 153 154 153 154 <sup xmlns:xlink="http://www.w3.org/1999/xlink">a</sup>
###xml 153 154 153 154 <italic xmlns:xlink="http://www.w3.org/1999/xlink"><sup>a</sup></italic>
###xml 153 154 153 154 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic><sup>a</sup></italic></bold>
###xml 153 154 153 154 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table-fn" rid="tblfn3"><bold><italic><sup>a</sup></italic></bold></xref>
###xml 146 154 146 154 <th xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"><bold>Protein</bold><xref ref-type="table-fn" rid="tblfn3"><bold><italic><sup>a</sup></italic></bold></xref></th>
###xml 155 156 155 156 <sub xmlns:xlink="http://www.w3.org/1999/xlink">d</sub>
###xml 154 156 154 156 <italic xmlns:xlink="http://www.w3.org/1999/xlink">K<sub>d</sub></italic>
###xml 154 162 154 162 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>K<sub>d</sub></italic> TSG-6</bold>
###xml 154 162 154 162 <th xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"><bold><italic>K<sub>d</sub></italic> TSG-6</bold></th>
###xml 163 164 163 164 <sub xmlns:xlink="http://www.w3.org/1999/xlink">d</sub>
###xml 162 164 162 164 <italic xmlns:xlink="http://www.w3.org/1999/xlink">K<sub>d</sub></italic>
###xml 162 174 162 174 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>K<sub>d</sub></italic> Link_TSG6</bold>
###xml 162 174 162 174 <th xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"><bold><italic>K<sub>d</sub></italic> Link_TSG6</bold></th>
###xml 175 176 175 176 <sub xmlns:xlink="http://www.w3.org/1999/xlink">d</sub>
###xml 174 176 174 176 <italic xmlns:xlink="http://www.w3.org/1999/xlink">K<sub>d</sub></italic>
###xml 174 187 174 187 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>K<sub>d</sub></italic> CUB_C_TSG6</bold>
###xml 174 187 174 187 <th xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"><bold><italic>K<sub>d</sub></italic> CUB_C_TSG6</bold></th>
###xml 146 187 146 187 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><th colspan="1" rowspan="1" align="center" valign="top"><bold>Protein</bold><xref ref-type="table-fn" rid="tblfn3"><bold><italic><sup>a</sup></italic></bold></xref></th><th colspan="1" rowspan="1" align="center" valign="top"><bold><italic>K<sub>d</sub></italic> TSG-6</bold></th><th colspan="1" rowspan="1" align="center" valign="top"><bold><italic>K<sub>d</sub></italic> Link_TSG6</bold></th><th colspan="1" rowspan="1" align="center" valign="top"><bold><italic>K<sub>d</sub></italic> CUB_C_TSG6</bold></th></tr>
###xml 146 187 146 187 <thead xmlns:xlink="http://www.w3.org/1999/xlink"><tr><th colspan="1" rowspan="1" align="center" valign="top"><bold>Protein</bold><xref ref-type="table-fn" rid="tblfn3"><bold><italic><sup>a</sup></italic></bold></xref></th><th colspan="1" rowspan="1" align="center" valign="top"><bold><italic>K<sub>d</sub></italic> TSG-6</bold></th><th colspan="1" rowspan="1" align="center" valign="top"><bold><italic>K<sub>d</sub></italic> Link_TSG6</bold></th><th colspan="1" rowspan="1" align="center" valign="top"><bold><italic>K<sub>d</sub></italic> CUB_C_TSG6</bold></th></tr></thead>
###xml 187 187 187 187 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="top"/>
###xml 190 191 189 190 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 190 191 189 190 <italic xmlns:xlink="http://www.w3.org/1999/xlink"><sc>m</sc></italic>
###xml 187 191 187 190 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> &#956;<italic><sc>m</sc></italic></td>
###xml 194 195 192 193 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 194 195 192 193 <italic xmlns:xlink="http://www.w3.org/1999/xlink"><sc>m</sc></italic>
###xml 191 195 190 193 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> &#956;<italic><sc>m</sc></italic></td>
###xml 198 199 195 196 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 198 199 195 196 <italic xmlns:xlink="http://www.w3.org/1999/xlink"><sc>m</sc></italic>
###xml 195 199 193 196 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> &#956;<italic><sc>m</sc></italic></td>
###xml 187 199 187 196 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td colspan="1" rowspan="1" align="left" valign="top"/><td colspan="1" rowspan="1" align="center" valign="top"> &#956;<italic><sc>m</sc></italic></td><td colspan="1" rowspan="1" align="center" valign="top"> &#956;<italic><sc>m</sc></italic></td><td colspan="1" rowspan="1" align="center" valign="top"> &#956;<italic><sc>m</sc></italic></td></tr>
###xml 199 206 196 203 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="top"> BMP-2 </td>
###xml 212 213 209 210 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b</sup>
###xml 212 213 209 210 <italic xmlns:xlink="http://www.w3.org/1999/xlink"><sup>b</sup></italic>
###xml 212 213 209 210 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table-fn" rid="tblfn4"><italic><sup>b</sup></italic></xref>
###xml 206 213 203 210 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="top"> 0.220<xref ref-type="table-fn" rid="tblfn4"><italic><sup>b</sup></italic></xref></td>
###xml 213 219 210 216 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> 2.43 </td>
###xml 219 225 216 222 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> 2.54 </td>
###xml 199 225 196 222 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td colspan="1" rowspan="1" align="left" valign="top"> BMP-2 </td><td colspan="1" rowspan="1" align="left" valign="top"> 0.220<xref ref-type="table-fn" rid="tblfn4"><italic><sup>b</sup></italic></xref></td><td colspan="1" rowspan="1" align="center" valign="top"> 2.43 </td><td colspan="1" rowspan="1" align="center" valign="top"> 2.54 </td></tr>
###xml 225 233 222 230 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="top"> BMP-13 </td>
###xml 233 240 230 237 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="top"> 0.236 </td>
###xml 240 246 237 243 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> 2.84 </td>
###xml 246 252 243 249 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> 6.88 </td>
###xml 225 252 222 249 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td colspan="1" rowspan="1" align="left" valign="top"> BMP-13 </td><td colspan="1" rowspan="1" align="left" valign="top"> 0.236 </td><td colspan="1" rowspan="1" align="center" valign="top"> 2.84 </td><td colspan="1" rowspan="1" align="center" valign="top"> 6.88 </td></tr>
###xml 252 260 249 257 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="top"> BMP-14 </td>
###xml 260 267 257 264 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="top"> 0.184 </td>
###xml 267 273 264 270 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> 1.10 </td>
###xml 273 279 270 276 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> 10.8 </td>
###xml 252 279 249 276 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td colspan="1" rowspan="1" align="left" valign="top"> BMP-14 </td><td colspan="1" rowspan="1" align="left" valign="top"> 0.184 </td><td colspan="1" rowspan="1" align="center" valign="top"> 1.10 </td><td colspan="1" rowspan="1" align="center" valign="top"> 10.8 </td></tr>
###xml 279 287 276 284 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="top"> sRANKL </td>
###xml 287 293 284 290 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="top"> 1.97 </td>
###xml 293 299 290 296 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> 8.25 </td>
###xml 301 302 298 299 <sup xmlns:xlink="http://www.w3.org/1999/xlink">c</sup>
###xml 301 302 298 299 <italic xmlns:xlink="http://www.w3.org/1999/xlink"><sup>c</sup></italic>
###xml 301 302 298 299 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table-fn" rid="tblfn5"><italic><sup>c</sup></italic></xref>
###xml 299 302 296 299 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> &#8212;<xref ref-type="table-fn" rid="tblfn5"><italic><sup>c</sup></italic></xref></td>
###xml 279 302 276 299 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td colspan="1" rowspan="1" align="left" valign="top"> sRANKL </td><td colspan="1" rowspan="1" align="left" valign="top"> 1.97 </td><td colspan="1" rowspan="1" align="center" valign="top"> 8.25 </td><td colspan="1" rowspan="1" align="center" valign="top"> &#8212;<xref ref-type="table-fn" rid="tblfn5"><italic><sup>c</sup></italic></xref></td></tr>
###xml 187 302 187 299 <tbody xmlns:xlink="http://www.w3.org/1999/xlink"><tr><td colspan="1" rowspan="1" align="left" valign="top"/><td colspan="1" rowspan="1" align="center" valign="top"> &#956;<italic><sc>m</sc></italic></td><td colspan="1" rowspan="1" align="center" valign="top"> &#956;<italic><sc>m</sc></italic></td><td colspan="1" rowspan="1" align="center" valign="top"> &#956;<italic><sc>m</sc></italic></td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> BMP-2 </td><td colspan="1" rowspan="1" align="left" valign="top"> 0.220<xref ref-type="table-fn" rid="tblfn4"><italic><sup>b</sup></italic></xref></td><td colspan="1" rowspan="1" align="center" valign="top"> 2.43 </td><td colspan="1" rowspan="1" align="center" valign="top"> 2.54 </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> BMP-13 </td><td colspan="1" rowspan="1" align="left" valign="top"> 0.236 </td><td colspan="1" rowspan="1" align="center" valign="top"> 2.84 </td><td colspan="1" rowspan="1" align="center" valign="top"> 6.88 </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> BMP-14 </td><td colspan="1" rowspan="1" align="left" valign="top"> 0.184 </td><td colspan="1" rowspan="1" align="center" valign="top"> 1.10 </td><td colspan="1" rowspan="1" align="center" valign="top"> 10.8 </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> sRANKL </td><td colspan="1" rowspan="1" align="left" valign="top"> 1.97 </td><td colspan="1" rowspan="1" align="center" valign="top"> 8.25 </td><td colspan="1" rowspan="1" align="center" valign="top"> &#8212;<xref ref-type="table-fn" rid="tblfn5"><italic><sup>c</sup></italic></xref></td></tr></tbody>
###xml 146 302 146 299 <table xmlns:xlink="http://www.w3.org/1999/xlink" frame="hsides" rules="groups"><thead><tr><th colspan="1" rowspan="1" align="center" valign="top"><bold>Protein</bold><xref ref-type="table-fn" rid="tblfn3"><bold><italic><sup>a</sup></italic></bold></xref></th><th colspan="1" rowspan="1" align="center" valign="top"><bold><italic>K<sub>d</sub></italic> TSG-6</bold></th><th colspan="1" rowspan="1" align="center" valign="top"><bold><italic>K<sub>d</sub></italic> Link_TSG6</bold></th><th colspan="1" rowspan="1" align="center" valign="top"><bold><italic>K<sub>d</sub></italic> CUB_C_TSG6</bold></th></tr></thead><tbody><tr><td colspan="1" rowspan="1" align="left" valign="top"/><td colspan="1" rowspan="1" align="center" valign="top"> &#956;<italic><sc>m</sc></italic></td><td colspan="1" rowspan="1" align="center" valign="top"> &#956;<italic><sc>m</sc></italic></td><td colspan="1" rowspan="1" align="center" valign="top"> &#956;<italic><sc>m</sc></italic></td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> BMP-2 </td><td colspan="1" rowspan="1" align="left" valign="top"> 0.220<xref ref-type="table-fn" rid="tblfn4"><italic><sup>b</sup></italic></xref></td><td colspan="1" rowspan="1" align="center" valign="top"> 2.43 </td><td colspan="1" rowspan="1" align="center" valign="top"> 2.54 </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> BMP-13 </td><td colspan="1" rowspan="1" align="left" valign="top"> 0.236 </td><td colspan="1" rowspan="1" align="center" valign="top"> 2.84 </td><td colspan="1" rowspan="1" align="center" valign="top"> 6.88 </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> BMP-14 </td><td colspan="1" rowspan="1" align="left" valign="top"> 0.184 </td><td colspan="1" rowspan="1" align="center" valign="top"> 1.10 </td><td colspan="1" rowspan="1" align="center" valign="top"> 10.8 </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> sRANKL </td><td colspan="1" rowspan="1" align="left" valign="top"> 1.97 </td><td colspan="1" rowspan="1" align="center" valign="top"> 8.25 </td><td colspan="1" rowspan="1" align="center" valign="top"> &#8212;<xref ref-type="table-fn" rid="tblfn5"><italic><sup>c</sup></italic></xref></td></tr></tbody></table>
###xml 302 303 299 300 <label xmlns:xlink="http://www.w3.org/1999/xlink">a</label>
###xml 303 432 300 429 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="44">Each experiment was performed in duplicate with the average values shown here; all interactions conformed to a 1:1 Langmuir model</p>
###xml 302 432 299 429 <fn xmlns:xlink="http://www.w3.org/1999/xlink" id="tblfn3"><label>a</label><p textid="44">Each experiment was performed in duplicate with the average values shown here; all interactions conformed to a 1:1 Langmuir model</p></fn>
###xml 432 433 429 430 <label xmlns:xlink="http://www.w3.org/1999/xlink">b</label>
###xml 433 498 430 495 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="45">Dissociation constants are expressed to three significant figures</p>
###xml 432 498 429 495 <fn xmlns:xlink="http://www.w3.org/1999/xlink" id="tblfn4"><label>b</label><p textid="45">Dissociation constants are expressed to three significant figures</p></fn>
###xml 498 499 495 496 <label xmlns:xlink="http://www.w3.org/1999/xlink">c</label>
###xml 499 639 496 636 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="46">A value could not be obtained due to the low level of signal (response units) detected, combined with nonspecific binding to the sensor chip</p>
###xml 498 639 495 636 <fn xmlns:xlink="http://www.w3.org/1999/xlink" id="tblfn5"><label>c</label><p textid="46">A value could not be obtained due to the low level of signal (response units) detected, combined with nonspecific binding to the sensor chip</p></fn>
###xml 302 639 299 636 <table-wrap-foot xmlns:xlink="http://www.w3.org/1999/xlink"><fn id="tblfn3"><label>a</label><p textid="44">Each experiment was performed in duplicate with the average values shown here; all interactions conformed to a 1:1 Langmuir model</p></fn><fn id="tblfn4"><label>b</label><p textid="45">Dissociation constants are expressed to three significant figures</p></fn><fn id="tblfn5"><label>c</label><p textid="46">A value could not be obtained due to the low level of signal (response units) detected, combined with nonspecific binding to the sensor chip</p></fn></table-wrap-foot>
###xml 0 639 0 636 <table-wrap xmlns:xlink="http://www.w3.org/1999/xlink" position="float" id="tbl2"><label>TABLE 2</label><caption><p textid="43"><bold>Dissociation constants for the interactions of TSG-6 and its isolated domains with BMPs and sRANKL, determined by surface plasmon resonance</bold></p></caption><table frame="hsides" rules="groups"><thead><tr><th colspan="1" rowspan="1" align="center" valign="top"><bold>Protein</bold><xref ref-type="table-fn" rid="tblfn3"><bold><italic><sup>a</sup></italic></bold></xref></th><th colspan="1" rowspan="1" align="center" valign="top"><bold><italic>K<sub>d</sub></italic> TSG-6</bold></th><th colspan="1" rowspan="1" align="center" valign="top"><bold><italic>K<sub>d</sub></italic> Link_TSG6</bold></th><th colspan="1" rowspan="1" align="center" valign="top"><bold><italic>K<sub>d</sub></italic> CUB_C_TSG6</bold></th></tr></thead><tbody><tr><td colspan="1" rowspan="1" align="left" valign="top"/><td colspan="1" rowspan="1" align="center" valign="top"> &#956;<italic><sc>m</sc></italic></td><td colspan="1" rowspan="1" align="center" valign="top"> &#956;<italic><sc>m</sc></italic></td><td colspan="1" rowspan="1" align="center" valign="top"> &#956;<italic><sc>m</sc></italic></td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> BMP-2 </td><td colspan="1" rowspan="1" align="left" valign="top"> 0.220<xref ref-type="table-fn" rid="tblfn4"><italic><sup>b</sup></italic></xref></td><td colspan="1" rowspan="1" align="center" valign="top"> 2.43 </td><td colspan="1" rowspan="1" align="center" valign="top"> 2.54 </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> BMP-13 </td><td colspan="1" rowspan="1" align="left" valign="top"> 0.236 </td><td colspan="1" rowspan="1" align="center" valign="top"> 2.84 </td><td colspan="1" rowspan="1" align="center" valign="top"> 6.88 </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> BMP-14 </td><td colspan="1" rowspan="1" align="left" valign="top"> 0.184 </td><td colspan="1" rowspan="1" align="center" valign="top"> 1.10 </td><td colspan="1" rowspan="1" align="center" valign="top"> 10.8 </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> sRANKL </td><td colspan="1" rowspan="1" align="left" valign="top"> 1.97 </td><td colspan="1" rowspan="1" align="center" valign="top"> 8.25 </td><td colspan="1" rowspan="1" align="center" valign="top"> &#8212;<xref ref-type="table-fn" rid="tblfn5"><italic><sup>c</sup></italic></xref></td></tr></tbody></table><table-wrap-foot><fn id="tblfn3"><label>a</label><p textid="44">Each experiment was performed in duplicate with the average values shown here; all interactions conformed to a 1:1 Langmuir model</p></fn><fn id="tblfn4"><label>b</label><p textid="45">Dissociation constants are expressed to three significant figures</p></fn><fn id="tblfn5"><label>c</label><p textid="46">A value could not be obtained due to the low level of signal (response units) detected, combined with nonspecific binding to the sensor chip</p></fn></table-wrap-foot></table-wrap>
TABLE 2Dissociation constants for the interactions of TSG-6 and its isolated domains with BMPs and sRANKL, determined by surface plasmon resonanceProteinaKd TSG-6Kd Link_TSG6Kd CUB_C_TSG6 mum mum mum BMP-2  0.220b 2.43  2.54  BMP-13  0.236  2.84  6.88  BMP-14  0.184  1.10  10.8  sRANKL  1.97  8.25  -caEach experiment was performed in duplicate with the average values shown here; all interactions conformed to a 1:1 Langmuir modelbDissociation constants are expressed to three significant figurescA value could not be obtained due to the low level of signal (response units) detected, combined with nonspecific binding to the sensor chip
###end p 42
###begin p 43
###xml 0 139 0 139 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Dissociation constants for the interactions of TSG-6 and its isolated domains with BMPs and sRANKL, determined by surface plasmon resonance</bold>
Dissociation constants for the interactions of TSG-6 and its isolated domains with BMPs and sRANKL, determined by surface plasmon resonance
###end p 43
###begin p 44
Each experiment was performed in duplicate with the average values shown here; all interactions conformed to a 1:1 Langmuir model
###end p 44
###begin p 45
Dissociation constants are expressed to three significant figures
###end p 45
###begin p 46
A value could not be obtained due to the low level of signal (response units) detected, combined with nonspecific binding to the sensor chip
###end p 46
###begin p 47
###xml 151 152 151 152 <italic xmlns:xlink="http://www.w3.org/1999/xlink">a</italic>
###xml 157 158 157 158 <italic xmlns:xlink="http://www.w3.org/1999/xlink">b</italic>
###xml 143 158 143 158 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig8" ref-type="fig">Fig. 8, <italic>a</italic> and <italic>b</italic></xref>
###xml 392 393 392 393 <italic xmlns:xlink="http://www.w3.org/1999/xlink">c</italic>
###xml 386 393 386 393 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig8" ref-type="fig">Fig. 8<italic>c</italic></xref>
###xml 843 847 831 835 <italic xmlns:xlink="http://www.w3.org/1999/xlink">i.e.</italic>
###xml 864 865 851 852 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 919 920 906 907 <sub xmlns:xlink="http://www.w3.org/1999/xlink">d</sub>
###xml 918 920 905 907 <italic xmlns:xlink="http://www.w3.org/1999/xlink">K<sub>d</sub></italic>
###xml 947 954 934 941 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="tbl1">Table 1</xref>
We also investigated the interactions TSG-6, Link_TSG6, and CUB_C_TSG6 with sRANKL by ELISA and surface plasmon resonance. As can be seen from Fig. 8, a and b, full-length TSG-6 binds well to immobilized sRANKL, whereas equivalent amounts (5 pmol/well) of Link_TSG6 or the CUB_C domain show less binding. Similarly, when sRANKL was incubated with plates coated with the TSG-6 proteins (Fig. 8c), the extent of binding to Link_TSG6 and CUB_C_TSG6 was lower than that seen for the full-length protein. These data suggest that, like BMP-2, -13, and -14, sRANKL binds to a composite interaction surface involving both the Link and CUB_C domains of TSG-6. Consistent with this, surface plasmon resonance analysis revealed that full-length TSG-6 bound to immobilized sRANKL with an approximately4-fold higher affinity than the isolated Link module (i.e. about 2 and 8 mum, respectively), although we were unable to obtain a Kd value for CUB_C_TSG6 (see Table 1).
###end p 47
###begin p 48
###xml 0 9 0 9 <label xmlns:xlink="http://www.w3.org/1999/xlink">FIGURE 5.</label>
###xml 9 57 9 57 <bold xmlns:xlink="http://www.w3.org/1999/xlink">TSG-6 inhibits BMP-2-induced osteoblastogenesis.</bold>
###xml 105 106 105 106 <italic xmlns:xlink="http://www.w3.org/1999/xlink">a</italic>
###xml 122 123 122 123 <italic xmlns:xlink="http://www.w3.org/1999/xlink">b</italic>
###xml 371 372 371 372 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 445 447 443 445 <sup xmlns:xlink="http://www.w3.org/1999/xlink">**</sup>
###xml 452 455 450 453 <sup xmlns:xlink="http://www.w3.org/1999/xlink">***</sup>
###xml 458 459 456 457 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 471 472 469 470 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 539 540 537 538 <italic xmlns:xlink="http://www.w3.org/1999/xlink">a</italic>
###xml 593 594 591 592 <italic xmlns:xlink="http://www.w3.org/1999/xlink">b</italic>
###xml 759 760 746 747 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 9 839 9 826 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="49"><bold>TSG-6 inhibits BMP-2-induced osteoblastogenesis.</bold> The murine pre-osteoblast cell lines MBA-15.4 (<italic>a</italic>) and MC3T3-E1 (<italic>b</italic>) were cultured for 7 days with BMP-2 in the absence or presence of rhTSG-6 (at 0&#8211;10000 ng/ml) or molar equivalents of Link_TSG6 or CUB_C_TSG6. ALP activity was measured, and values were plotted as the mean ALP activity as a percentage of control (<italic>n</italic> = 8 &#177; S.E.) where the addition of BMP-2 alone was normalized to 100%; <sup>**</sup> and <sup>***</sup> = <italic>p</italic> &lt; 0.01 and <italic>p</italic> &lt; 0.001, respectively, compared with BMP-2 alone. MBA-15.4 cells (<italic>a</italic>) were more responsive to BMP-2 than MC3T3-E1 cells (<italic>b</italic>), with ALP activity up-regulated by 272 and 37%, respectively. &#167;, data for control cells with no added rhTSG-6, Link_TSG6, or CUB_C_TSG6 are shown as 0 p<sc>m</sc> protein; data from cells with added TSG-6 proteins are plotted on a log scale.</p>
###xml 9 839 9 826 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="49"><bold>TSG-6 inhibits BMP-2-induced osteoblastogenesis.</bold> The murine pre-osteoblast cell lines MBA-15.4 (<italic>a</italic>) and MC3T3-E1 (<italic>b</italic>) were cultured for 7 days with BMP-2 in the absence or presence of rhTSG-6 (at 0&#8211;10000 ng/ml) or molar equivalents of Link_TSG6 or CUB_C_TSG6. ALP activity was measured, and values were plotted as the mean ALP activity as a percentage of control (<italic>n</italic> = 8 &#177; S.E.) where the addition of BMP-2 alone was normalized to 100%; <sup>**</sup> and <sup>***</sup> = <italic>p</italic> &lt; 0.01 and <italic>p</italic> &lt; 0.001, respectively, compared with BMP-2 alone. MBA-15.4 cells (<italic>a</italic>) were more responsive to BMP-2 than MC3T3-E1 cells (<italic>b</italic>), with ALP activity up-regulated by 272 and 37%, respectively. &#167;, data for control cells with no added rhTSG-6, Link_TSG6, or CUB_C_TSG6 are shown as 0 p<sc>m</sc> protein; data from cells with added TSG-6 proteins are plotted on a log scale.</p></caption>
###xml 839 839 826 826 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="zbc0370847930005"/>
###xml 0 839 0 826 <fig xmlns:xlink="http://www.w3.org/1999/xlink" position="float" id="fig5"><label>FIGURE 5.</label><caption><p textid="49"><bold>TSG-6 inhibits BMP-2-induced osteoblastogenesis.</bold> The murine pre-osteoblast cell lines MBA-15.4 (<italic>a</italic>) and MC3T3-E1 (<italic>b</italic>) were cultured for 7 days with BMP-2 in the absence or presence of rhTSG-6 (at 0&#8211;10000 ng/ml) or molar equivalents of Link_TSG6 or CUB_C_TSG6. ALP activity was measured, and values were plotted as the mean ALP activity as a percentage of control (<italic>n</italic> = 8 &#177; S.E.) where the addition of BMP-2 alone was normalized to 100%; <sup>**</sup> and <sup>***</sup> = <italic>p</italic> &lt; 0.01 and <italic>p</italic> &lt; 0.001, respectively, compared with BMP-2 alone. MBA-15.4 cells (<italic>a</italic>) were more responsive to BMP-2 than MC3T3-E1 cells (<italic>b</italic>), with ALP activity up-regulated by 272 and 37%, respectively. &#167;, data for control cells with no added rhTSG-6, Link_TSG6, or CUB_C_TSG6 are shown as 0 p<sc>m</sc> protein; data from cells with added TSG-6 proteins are plotted on a log scale.</p></caption><graphic xlink:href="zbc0370847930005"/></fig>
###xml 62 68 <span type="species:ncbi:10090">murine</span>
FIGURE 5.TSG-6 inhibits BMP-2-induced osteoblastogenesis. The murine pre-osteoblast cell lines MBA-15.4 (a) and MC3T3-E1 (b) were cultured for 7 days with BMP-2 in the absence or presence of rhTSG-6 (at 0-10000 ng/ml) or molar equivalents of Link_TSG6 or CUB_C_TSG6. ALP activity was measured, and values were plotted as the mean ALP activity as a percentage of control (n = 8 +/- S.E.) where the addition of BMP-2 alone was normalized to 100%; ** and *** = p < 0.01 and p < 0.001, respectively, compared with BMP-2 alone. MBA-15.4 cells (a) were more responsive to BMP-2 than MC3T3-E1 cells (b), with ALP activity up-regulated by 272 and 37%, respectively. section sign, data for control cells with no added rhTSG-6, Link_TSG6, or CUB_C_TSG6 are shown as 0 pm protein; data from cells with added TSG-6 proteins are plotted on a log scale.
###end p 48
###begin p 49
###xml 0 48 0 48 <bold xmlns:xlink="http://www.w3.org/1999/xlink">TSG-6 inhibits BMP-2-induced osteoblastogenesis.</bold>
###xml 96 97 96 97 <italic xmlns:xlink="http://www.w3.org/1999/xlink">a</italic>
###xml 113 114 113 114 <italic xmlns:xlink="http://www.w3.org/1999/xlink">b</italic>
###xml 362 363 362 363 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 436 438 434 436 <sup xmlns:xlink="http://www.w3.org/1999/xlink">**</sup>
###xml 443 446 441 444 <sup xmlns:xlink="http://www.w3.org/1999/xlink">***</sup>
###xml 449 450 447 448 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 462 463 460 461 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 530 531 528 529 <italic xmlns:xlink="http://www.w3.org/1999/xlink">a</italic>
###xml 584 585 582 583 <italic xmlns:xlink="http://www.w3.org/1999/xlink">b</italic>
###xml 750 751 737 738 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 53 59 <span type="species:ncbi:10090">murine</span>
TSG-6 inhibits BMP-2-induced osteoblastogenesis. The murine pre-osteoblast cell lines MBA-15.4 (a) and MC3T3-E1 (b) were cultured for 7 days with BMP-2 in the absence or presence of rhTSG-6 (at 0-10000 ng/ml) or molar equivalents of Link_TSG6 or CUB_C_TSG6. ALP activity was measured, and values were plotted as the mean ALP activity as a percentage of control (n = 8 +/- S.E.) where the addition of BMP-2 alone was normalized to 100%; ** and *** = p < 0.01 and p < 0.001, respectively, compared with BMP-2 alone. MBA-15.4 cells (a) were more responsive to BMP-2 than MC3T3-E1 cells (b), with ALP activity up-regulated by 272 and 37%, respectively. section sign, data for control cells with no added rhTSG-6, Link_TSG6, or CUB_C_TSG6 are shown as 0 pm protein; data from cells with added TSG-6 proteins are plotted on a log scale.
###end p 49
###begin p 50
###xml 256 257 256 257 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">2</xref>
###xml 262 263 262 263 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">5</xref>
As described above, BMP-2 and sRANKL both bind with higher affinity to the intact TSG-6 protein compared with its isolated domains. In addition, the full-length protein has more potent biological effects than the Link_TSG6 or CUB_C_TSG6 domains (see Figs. 2 and 5). Together this provides evidence that TSG-6-mediated inhibition of osteoblastogenesis and of osteoclastic resorption is likely to be mediated via its direct interaction with BMP-2 and RANKL, respectively.
###end p 50
###begin p 51
###xml 0 9 0 9 <label xmlns:xlink="http://www.w3.org/1999/xlink">FIGURE 6.</label>
###xml 9 61 9 61 <bold xmlns:xlink="http://www.w3.org/1999/xlink">TSG-6 interacts with members of the BMP superfamily.</bold>
###xml 191 192 191 192 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 9 310 9 308 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="52"><bold>TSG-6 interacts with members of the BMP superfamily.</bold> The binding of rhTSG-6 to BMP-coated wells was determined colorimetrically. Values are plotted as the mean absorbance at 405 nm (<italic>n</italic> = 4 &#177; S.E.) after a 30-min development time. These data are representative of two or three independent experiments.</p>
###xml 9 310 9 308 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="52"><bold>TSG-6 interacts with members of the BMP superfamily.</bold> The binding of rhTSG-6 to BMP-coated wells was determined colorimetrically. Values are plotted as the mean absorbance at 405 nm (<italic>n</italic> = 4 &#177; S.E.) after a 30-min development time. These data are representative of two or three independent experiments.</p></caption>
###xml 310 310 308 308 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="zbc0370847930006"/>
###xml 0 310 0 308 <fig xmlns:xlink="http://www.w3.org/1999/xlink" position="float" id="fig6"><label>FIGURE 6.</label><caption><p textid="52"><bold>TSG-6 interacts with members of the BMP superfamily.</bold> The binding of rhTSG-6 to BMP-coated wells was determined colorimetrically. Values are plotted as the mean absorbance at 405 nm (<italic>n</italic> = 4 &#177; S.E.) after a 30-min development time. These data are representative of two or three independent experiments.</p></caption><graphic xlink:href="zbc0370847930006"/></fig>
FIGURE 6.TSG-6 interacts with members of the BMP superfamily. The binding of rhTSG-6 to BMP-coated wells was determined colorimetrically. Values are plotted as the mean absorbance at 405 nm (n = 4 +/- S.E.) after a 30-min development time. These data are representative of two or three independent experiments.
###end p 51
###begin p 52
###xml 0 52 0 52 <bold xmlns:xlink="http://www.w3.org/1999/xlink">TSG-6 interacts with members of the BMP superfamily.</bold>
###xml 182 183 182 183 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
TSG-6 interacts with members of the BMP superfamily. The binding of rhTSG-6 to BMP-coated wells was determined colorimetrically. Values are plotted as the mean absorbance at 405 nm (n = 4 +/- S.E.) after a 30-min development time. These data are representative of two or three independent experiments.
###end p 52
###begin title 53
DISCUSSION
###end title 53
###begin p 54
###xml 102 104 102 104 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref31">31</xref>
###xml 105 107 105 107 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref35">35</xref>
Although it is well established that TSG-6 is protective in various experimental models of arthritis (31-35), the exact mechanism(s) by which its effects are mediated remains unclear. Here we have identified two novel functions for TSG-6; it inhibits both sRANKL-induced bone resorption by osteoclasts and BMP-2-induced osteoblast differentiation, which may have a key role in protecting joint tissues during disease and in the regulation of bone homeostasis.
###end p 54
###begin p 55
###xml 396 400 396 400 <italic xmlns:xlink="http://www.w3.org/1999/xlink">e.g.</italic>
###xml 508 510 508 510 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref22">22</xref>
###xml 642 644 642 644 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref12">12</xref>
Our functional and ligand binding studies suggest that these activities of TSG-6 are mediated through its interactions with RANKL or BMP-2 (and possibly other BMPs), respectively, where both of these are likely to require composite binding surfaces involving the Link module and CUB_C domain of TSG-6. In this respect, the new binding partners reported here differ from most other TSG-6 ligands (e.g. HA, heparin, bikunin, pentraxin-3, and thrombospondin-1), which have binding sites within the Link module (22). At present, the only known ligand that binds outside this region of TSG-6 is fibronectin, which interacts with the CUB_C domain (12).
###end p 55
###begin p 56
###xml 58 63 58 63 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TSG-6</italic>
###xml 63 66 63 66 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 228 233 228 233 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TSG-6</italic>
###xml 233 236 233 236 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 279 281 279 281 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref35">35</xref>
###xml 372 376 372 376 <italic xmlns:xlink="http://www.w3.org/1999/xlink">e.g.</italic>
###xml 67 71 <span type="species:ncbi:10090">mice</span>
###xml 237 241 <span type="species:ncbi:10090">mice</span>
In this study we have shown that osteoclasts derived from TSG-6-/- mice give rise to a marked elevation in dentine resorption compared with those from wild type controls, which is consistent with the severe bone erosion seen in TSG-6-/- mice with proteoglycan-induced arthritis (35). These experiments also demonstrate that TSG-6 is produced by bone marrow-derived cells (e.g. pre-osteoclasts and/or stromal cells) in response to stimulation with sRANKL/M-CSF and, thus, that TSG-6 has an autocrine and/or paracrine function in this tissue.
###end p 56
###begin p 57
###xml 58 60 58 60 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref51">51</xref>
###xml 62 64 62 64 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref52">52</xref>
###xml 138 140 138 140 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref53">53</xref>
###xml 142 144 142 144 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref54">54</xref>
###xml 205 206 205 206 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 223 225 223 225 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref55">55</xref>
###xml 323 327 323 327 <italic xmlns:xlink="http://www.w3.org/1999/xlink">e.g.</italic>
###xml 345 347 345 347 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref56">56</xref>
###xml 421 423 421 423 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref57">57</xref>
###xml 564 566 564 566 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref58">58</xref>
###xml 641 646 <span type="species:ncbi:9606">human</span>
RANKL, the major regulator of osteoclast differentiation (51, 52), is expressed on osteoblasts as well as on dendritic cells and T cells (53, 54) in response to calciotropic factors such as prostaglandin E2, IL-1, and TNF (55). The combination of IL-1 or TNF with IL-17 is particularly potent at inducing RANKL expression, e.g. in synoviocytes (56). RANKL binds to its receptor RANK on mononuclear osteoclast precursors (57), where this interaction not only induces osteoclast differentiation but also stimulates the bone resorbing activity of mature osteoclasts (58). We have shown here that TSG-6 inhibits RANKL-induced bone resorption by human osteoclasts in a dose-dependent manner. Our data suggest that TSG-6 acts at the point of osteoclast activation, since we observed inhibition of dentine erosion, but no reduction in osteoclast number or size when TSG-6 was added to PBMC cultures. It seems reasonable to suggest that TSG-6 might mediate this effect by binding directly to RANKL, thereby blocking its association with RANK; however, further studies are required to demonstrate this definitively.
###end p 57
###begin p 58
###xml 0 9 0 9 <label xmlns:xlink="http://www.w3.org/1999/xlink">FIGURE 7.</label>
###xml 9 94 9 94 <bold xmlns:xlink="http://www.w3.org/1999/xlink">BMPs exhibit tighter binding to full-length TSG-6 than to its Link and CUB_C domains.</bold>
###xml 215 216 209 210 <italic xmlns:xlink="http://www.w3.org/1999/xlink">a</italic>
###xml 263 264 231 232 <italic xmlns:xlink="http://www.w3.org/1999/xlink">b</italic>
###xml 427 428 395 396 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 457 458 423 424 <italic xmlns:xlink="http://www.w3.org/1999/xlink">a</italic>
###xml 471 472 437 438 <italic xmlns:xlink="http://www.w3.org/1999/xlink">b</italic>
###xml 9 492 9 458 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="59"><bold>BMPs exhibit tighter binding to full-length TSG-6 than to its Link and CUB_C domains.</bold> The interactions of full-length rhTSG-6 (&#8226;) with immobilized BMP-2, -13, or -14 were compared with Link_TSG6 (&#9830;) (<italic>a</italic>) or CUB_C_TSG6 (&#9642;) (<italic>b</italic>). Protein binding was detected using antibodies specific for the Link module or CUB_C domain as appropriate. Values are plotted as the mean absorbance at 405 nm (<italic>n</italic> = 8 &#177; S.E.) after 60-min (<italic>a</italic>) or 30-min (<italic>b</italic>) development times.</p>
###xml 9 492 9 458 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="59"><bold>BMPs exhibit tighter binding to full-length TSG-6 than to its Link and CUB_C domains.</bold> The interactions of full-length rhTSG-6 (&#8226;) with immobilized BMP-2, -13, or -14 were compared with Link_TSG6 (&#9830;) (<italic>a</italic>) or CUB_C_TSG6 (&#9642;) (<italic>b</italic>). Protein binding was detected using antibodies specific for the Link module or CUB_C domain as appropriate. Values are plotted as the mean absorbance at 405 nm (<italic>n</italic> = 8 &#177; S.E.) after 60-min (<italic>a</italic>) or 30-min (<italic>b</italic>) development times.</p></caption>
###xml 492 492 458 458 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="zbc0370847930007"/>
###xml 0 492 0 458 <fig xmlns:xlink="http://www.w3.org/1999/xlink" position="float" id="fig7"><label>FIGURE 7.</label><caption><p textid="59"><bold>BMPs exhibit tighter binding to full-length TSG-6 than to its Link and CUB_C domains.</bold> The interactions of full-length rhTSG-6 (&#8226;) with immobilized BMP-2, -13, or -14 were compared with Link_TSG6 (&#9830;) (<italic>a</italic>) or CUB_C_TSG6 (&#9642;) (<italic>b</italic>). Protein binding was detected using antibodies specific for the Link module or CUB_C domain as appropriate. Values are plotted as the mean absorbance at 405 nm (<italic>n</italic> = 8 &#177; S.E.) after 60-min (<italic>a</italic>) or 30-min (<italic>b</italic>) development times.</p></caption><graphic xlink:href="zbc0370847930007"/></fig>
FIGURE 7.BMPs exhibit tighter binding to full-length TSG-6 than to its Link and CUB_C domains. The interactions of full-length rhTSG-6 (*) with immobilized BMP-2, -13, or -14 were compared with Link_TSG6 (diamond) (a) or CUB_C_TSG6 (blacksquare, square, filled) (b). Protein binding was detected using antibodies specific for the Link module or CUB_C domain as appropriate. Values are plotted as the mean absorbance at 405 nm (n = 8 +/- S.E.) after 60-min (a) or 30-min (b) development times.
###end p 58
###begin p 59
###xml 0 85 0 85 <bold xmlns:xlink="http://www.w3.org/1999/xlink">BMPs exhibit tighter binding to full-length TSG-6 than to its Link and CUB_C domains.</bold>
###xml 206 207 200 201 <italic xmlns:xlink="http://www.w3.org/1999/xlink">a</italic>
###xml 254 255 222 223 <italic xmlns:xlink="http://www.w3.org/1999/xlink">b</italic>
###xml 418 419 386 387 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 448 449 414 415 <italic xmlns:xlink="http://www.w3.org/1999/xlink">a</italic>
###xml 462 463 428 429 <italic xmlns:xlink="http://www.w3.org/1999/xlink">b</italic>
BMPs exhibit tighter binding to full-length TSG-6 than to its Link and CUB_C domains. The interactions of full-length rhTSG-6 (*) with immobilized BMP-2, -13, or -14 were compared with Link_TSG6 (diamond) (a) or CUB_C_TSG6 (blacksquare, square, filled) (b). Protein binding was detected using antibodies specific for the Link module or CUB_C domain as appropriate. Values are plotted as the mean absorbance at 405 nm (n = 8 +/- S.E.) after 60-min (a) or 30-min (b) development times.
###end p 59
###begin p 60
###xml 196 204 196 204 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 206 208 206 208 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref59">59</xref>
###xml 465 467 465 467 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref60">60</xref>
###xml 574 578 574 578 <italic xmlns:xlink="http://www.w3.org/1999/xlink">i.e.</italic>
###xml 777 778 764 765 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 864 866 851 853 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref61">61</xref>
###xml 901 907 888 894 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al.</italic>
###xml 909 911 896 898 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref61">61</xref>
###xml 957 958 944 945 <sub xmlns:xlink="http://www.w3.org/1999/xlink">d</sub>
###xml 956 958 943 945 <italic xmlns:xlink="http://www.w3.org/1999/xlink">K<sub>d</sub></italic>
###xml 965 966 952 953 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 1071 1075 1058 1062 <italic xmlns:xlink="http://www.w3.org/1999/xlink">i.e.</italic>
###xml 1103 1105 1090 1092 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref61">61</xref>
###xml 1237 1238 1224 1225 <sub xmlns:xlink="http://www.w3.org/1999/xlink">d</sub>
###xml 1236 1238 1223 1225 <italic xmlns:xlink="http://www.w3.org/1999/xlink">K<sub>d</sub></italic>
###xml 1259 1260 1233 1234 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 1504 1505 1478 1479 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M</italic>
###xml 1505 1506 1479 1480 <sub xmlns:xlink="http://www.w3.org/1999/xlink">r</sub>
###xml 1565 1566 1539 1540 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 1634 1636 1608 1610 <sub xmlns:xlink="http://www.w3.org/1999/xlink">50</sub>
###xml 1681 1682 1631 1632 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 1769 1771 1719 1721 <sub xmlns:xlink="http://www.w3.org/1999/xlink">50</sub>
###xml 1800 1801 1738 1739 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 1816 1817 1754 1755 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fn" rid="fn6">6</xref>
###xml 1993 1995 1931 1933 <sub xmlns:xlink="http://www.w3.org/1999/xlink">50</sub>
###xml 2043 2044 1969 1970 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 2047 2049 1973 1975 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref62">62</xref>
###xml 2122 2130 2048 2056 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 235 239 <span type="species:ncbi:10116">rats</span>
###xml 1700 1705 <span type="species:ncbi:9606">human</span>
###xml 1944 1949 <span type="species:ncbi:9606">human</span>
At present, osteoprotegerin (OPG), a soluble decoy receptor for RANKL, is the only known antagonist of the RANKL/RANK interaction that can effectively inhibit osteoclast maturation and activation in vitro (59). Furthermore, studies on rats with antigen-induced arthritis showed RANKL (expressed on the surface of synovial effector T cells) to be the key mediator of joint damage and bone erosion, where treatment with OPG provided protection against these effects (60). The ability of TSG-6 to inhibit RANKL-induced osteoclast activity, possibly in a manner similar to OPG (i.e. via a direct interaction with RANKL), thus makes it a potential model for the development of therapeutics. The dissociation constant observed here for the TSG-6/sRANKL interaction (approximately2 mum) is 3 orders of magnitude higher than that reported for the binding of OPG to RANKL (61). However, as noted by Schneeweis et al. (61), the tight binding observed for OPG/RANKL (Kd = 10 nm) is likely to be due the formation of 1:1 complexes between homodimers of OPG and homotrimers of RANKL, i.e. leading to a high avidity (61). Interestingly, a truncated form of OPG containing the RANKL-binding site but lacking the dimerization domain bound RANKL with a Kd of approximately3 mum. Our study utilized monomeric sRANKL, and it is possible that the interaction of TSG-6 with trimeric RANKL might have a considerably higher affinity; however, this remains to be investigated. In the lacunar resorption assay used here, sRANKL (Mr = 20 kDa) is present at a concentration of 50 ng/ml (2.5 nm), and we observed that rhTSG-6 inhibited dentine erosion with an IC50 of approximately15 ng/ml (approximately0.5 nm). By comparison, human recombinant OPG (R&D Systems; 43.5 kDa) was found to have an IC50 value of approximately0.25 nm in this assay.6 This is consistent with a previous investigation of osteoclast formation from arthrosplasty-derived macrophages, showing that human OPG inhibited lacunar resorption with an IC50 of between 50 and 100 ng/ml (approximately1.5 nm) (62). Overall this indicates that TSG-6 has a similar potency to OPG in the in vitro inhibition of osteoclastic resorption.
###end p 60
###begin p 61
###xml 0 9 0 9 <label xmlns:xlink="http://www.w3.org/1999/xlink">FIGURE 8.</label>
###xml 9 68 9 68 <bold xmlns:xlink="http://www.w3.org/1999/xlink">TSG-6 interacts with sRANKL via its Link and CUB_C domains.</bold>
###xml 174 175 174 175 <italic xmlns:xlink="http://www.w3.org/1999/xlink">a</italic>
###xml 180 181 180 181 <italic xmlns:xlink="http://www.w3.org/1999/xlink">b</italic>
###xml 202 203 202 203 <italic xmlns:xlink="http://www.w3.org/1999/xlink">c</italic>
###xml 300 301 300 301 <italic xmlns:xlink="http://www.w3.org/1999/xlink">a</italic>
###xml 312 313 312 313 <italic xmlns:xlink="http://www.w3.org/1999/xlink">b</italic>
###xml 327 328 327 328 <italic xmlns:xlink="http://www.w3.org/1999/xlink">c</italic>
###xml 362 363 362 363 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 9 378 9 376 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="62"><bold>TSG-6 interacts with sRANKL via its Link and CUB_C domains.</bold> The interactions of rhTSG-6, Link_TSG6, or CUB_C_TSG6 with sRANKL were compared where either the sRANKL (<italic>a</italic> and <italic>b</italic>) or TSG-6 proteins (<italic>c</italic>) were immobilized on microtiter plates. Absorbance values at 405 nm were measured after 20 min (<italic>a</italic>), 30 min (<italic>b</italic>), or 60 min (<italic>c</italic>) and are plotted as mean values (<italic>n</italic> = 8 &#177; S.E.).</p>
###xml 9 378 9 376 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="62"><bold>TSG-6 interacts with sRANKL via its Link and CUB_C domains.</bold> The interactions of rhTSG-6, Link_TSG6, or CUB_C_TSG6 with sRANKL were compared where either the sRANKL (<italic>a</italic> and <italic>b</italic>) or TSG-6 proteins (<italic>c</italic>) were immobilized on microtiter plates. Absorbance values at 405 nm were measured after 20 min (<italic>a</italic>), 30 min (<italic>b</italic>), or 60 min (<italic>c</italic>) and are plotted as mean values (<italic>n</italic> = 8 &#177; S.E.).</p></caption>
###xml 378 378 376 376 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="zbc0370847930008"/>
###xml 0 378 0 376 <fig xmlns:xlink="http://www.w3.org/1999/xlink" position="float" id="fig8"><label>FIGURE 8.</label><caption><p textid="62"><bold>TSG-6 interacts with sRANKL via its Link and CUB_C domains.</bold> The interactions of rhTSG-6, Link_TSG6, or CUB_C_TSG6 with sRANKL were compared where either the sRANKL (<italic>a</italic> and <italic>b</italic>) or TSG-6 proteins (<italic>c</italic>) were immobilized on microtiter plates. Absorbance values at 405 nm were measured after 20 min (<italic>a</italic>), 30 min (<italic>b</italic>), or 60 min (<italic>c</italic>) and are plotted as mean values (<italic>n</italic> = 8 &#177; S.E.).</p></caption><graphic xlink:href="zbc0370847930008"/></fig>
FIGURE 8.TSG-6 interacts with sRANKL via its Link and CUB_C domains. The interactions of rhTSG-6, Link_TSG6, or CUB_C_TSG6 with sRANKL were compared where either the sRANKL (a and b) or TSG-6 proteins (c) were immobilized on microtiter plates. Absorbance values at 405 nm were measured after 20 min (a), 30 min (b), or 60 min (c) and are plotted as mean values (n = 8 +/- S.E.).
###end p 61
###begin p 62
###xml 0 59 0 59 <bold xmlns:xlink="http://www.w3.org/1999/xlink">TSG-6 interacts with sRANKL via its Link and CUB_C domains.</bold>
###xml 165 166 165 166 <italic xmlns:xlink="http://www.w3.org/1999/xlink">a</italic>
###xml 171 172 171 172 <italic xmlns:xlink="http://www.w3.org/1999/xlink">b</italic>
###xml 193 194 193 194 <italic xmlns:xlink="http://www.w3.org/1999/xlink">c</italic>
###xml 291 292 291 292 <italic xmlns:xlink="http://www.w3.org/1999/xlink">a</italic>
###xml 303 304 303 304 <italic xmlns:xlink="http://www.w3.org/1999/xlink">b</italic>
###xml 318 319 318 319 <italic xmlns:xlink="http://www.w3.org/1999/xlink">c</italic>
###xml 353 354 353 354 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
TSG-6 interacts with sRANKL via its Link and CUB_C domains. The interactions of rhTSG-6, Link_TSG6, or CUB_C_TSG6 with sRANKL were compared where either the sRANKL (a and b) or TSG-6 proteins (c) were immobilized on microtiter plates. Absorbance values at 405 nm were measured after 20 min (a), 30 min (b), or 60 min (c) and are plotted as mean values (n = 8 +/- S.E.).
###end p 62
###begin p 63
###xml 34 39 34 39 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TSG-6</italic>
###xml 39 42 39 42 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 450 454 450 454 <italic xmlns:xlink="http://www.w3.org/1999/xlink">e.g.</italic>
###xml 615 621 615 621 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al.</italic>
###xml 623 625 623 625 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref63">63</xref>
###xml 1350 1352 1350 1352 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref12">12</xref>
###xml 1353 1355 1353 1355 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref14">14</xref>
###xml 1357 1359 1357 1359 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref18">18</xref>
###xml 1406 1412 1406 1412 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al.</italic>
###xml 1414 1416 1414 1416 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref63">63</xref>
###xml 1743 1749 1739 1745 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al.</italic>
###xml 1751 1753 1747 1749 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref63">63</xref>
###xml 43 47 <span type="species:ncbi:10090">mice</span>
###xml 728 733 <span type="species:ncbi:9606">human</span>
Our observation that unchallenged TSG-6-/- mice have higher trabecular bone mass than wild type controls might at first glance appear to be at odds with the inhibitory effect of TSG-6 on bone erosion described above. However, we hypothesize that, although TSG-6 inhibits osteoclast activity at inflammatory sites, it also has a pivotal role in normal bone homeostasis. This is supported by our finding that TSG-6 is expressed in normal joint tissue (e.g. in bone marrow) and that it significantly reduces the production of ALP (a marker of differentiation) by osteoblast precursors stimulated with BMP-2. Tsukahara et al. (63) have also described inhibition of BMP-2-mediated osteoblastogenesis after overexpression of TSG-6 in human mesenchymal stem cells (hMSC) or by the addition of partially purified recombinant TSG-6 proteins to hMSC cultures; binding of TSG-6 to BMP-2 was detected in these systems by immunoprecipitation. The authors proposed that the Link module of TSG-6 is responsible for inhibition of osteoblast differentiation via interaction with BMP-2, based on semiquantitative experiments using deletion mutants where, for example, protein lacking the Link module was found to be inactive. This conclusion is inconsistent with our results that were obtained using defined amounts of pure, highly characterized protein preparations (12-14, 18). It should be noted that, although Tsukahara et al. (63) report little or no inhibition of ALP expression or immunoprecipitation of BMP-2/TSG-6 complex with their deletion mutant lacking the Link module, their data also show a substantial reduction in these effects (compared with full-length TSG-6) with the DeltaCUB deletion mutant. We suggest that our data and that of Tsukahara et al. (63) are consistent with BMP-2 binding to a surface that involves both the Link and CUB modules of TSG-6.
###end p 63
###begin p 64
###xml 103 105 100 102 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref64">64</xref>
###xml 335 337 332 334 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref65">65</xref>
###xml 339 341 336 338 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref66">66</xref>
###xml 426 428 423 425 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref67">67</xref>
###xml 429 431 426 428 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref71">71</xref>
###xml 492 496 489 493 <italic xmlns:xlink="http://www.w3.org/1999/xlink">e.g.</italic>
###xml 545 547 542 544 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref72">72</xref>
###xml 597 599 594 596 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref73">73</xref>
###xml 664 666 661 663 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref74">74</xref>
###xml 743 747 740 744 <italic xmlns:xlink="http://www.w3.org/1999/xlink">i.e.</italic>
###xml 785 787 782 784 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref75">75</xref>
###xml 799 801 796 798 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref76">76</xref>
###xml 816 818 813 815 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref77">77</xref>
###xml 838 840 835 837 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref78">78</xref>
###xml 849 851 846 848 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref79">79</xref>
###xml 929 931 926 928 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref80">80</xref>
###xml 939 941 936 938 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref81">81</xref>
###xml 978 980 975 977 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref82">82</xref>
###xml 1151 1153 1148 1150 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref83">83</xref>
The ability of TSG-6 to interact with members of the TGFbeta/BMP superfamily closely related to BMP-2 (64), namely BMP-4, -5, -6, -7, -13, and -14, further supports the hypothesis that TSG-6 has a role in bone homeostasis. BMP-2, -6, -7, and -9 are important in inducing the differentiation of mesenchymal stem cells into osteoblasts (65, 66), whereas most other BMPs are able to stimulate osteogenesis in mature osteoblasts (67-71). TSG-6 might also have regulatory roles in other contexts, e.g. BMP-4 has been implicated in tooth development (72), BMP-2 and -4 are required for limb patterning (73), and BMP-2 is essential for the initiation of fracture repair (74). In this regard TSG-6 may function like some of the known BMP antagonists, i.e. those of the chordin family, noggin (75), gremlin (76), and brorin (77), as well as SOST (78), GDF3 (79), and the recently discovered suppressors of mineralization such as asporin (80), Nov (81), and osteoclast inhibitory lectin (82). Interestingly, we have shown that TSG-6 does not bind to BMP-3, an antagonist of osteogenic BMPs that blocks differentiation of osteoprogenitor cells into osteoblasts (83).
###end p 64
###begin p 65
###xml 130 134 130 134 <italic xmlns:xlink="http://www.w3.org/1999/xlink">e.g.</italic>
###xml 212 214 212 214 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref84">84</xref>
###xml 433 435 433 435 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref85">85</xref>
###xml 666 668 666 668 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref28">28</xref>
###xml 670 672 670 672 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref29">29</xref>
###xml 283 289 <span type="species:ncbi:10090">murine</span>
In addition to its role in osteogenesis, BMP-2 can induce cartilage formation and is expressed at elevated levels around lesions (e.g. in osteoarthritis), suggesting that it might contribute to cartilage repair (84). A recent study, looking at the effects of BMP-2 overexpression in murine knee joints, has shown that this protein promotes matrix turnover in cartilage with increased proteoglycan synthesis and aggrecan degradation (85). Furthermore, blocking of BMP-2 activity (by gremlin) in IL-1-damaged cartilage gave rise to an overall decrease in proteoglycan content. It is not yet known whether TSG-6, which is expressed by chondrocytes in response to IL-1 (28, 29), can inhibit BMP-2-mediated functions in cartilage and if so whether this contributes to its protective effects in arthritis.
###end p 65
###begin p 66
###xml 81 86 81 86 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TSG-6</italic>
###xml 86 89 86 89 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 174 181 174 181 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 319 327 319 327 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 433 437 433 437 <italic xmlns:xlink="http://www.w3.org/1999/xlink">e.g.</italic>
###xml 437 438 437 438 <sc xmlns:xlink="http://www.w3.org/1999/xlink">l</sc>
###xml 477 479 477 479 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref86">86</xref>
###xml 481 483 481 483 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref87">87</xref>
###xml 90 94 <span type="species:ncbi:10090">mice</span>
The significantly higher bone mass that we have observed in the present study in TSG-6-/- mice compared with wild type animals provides compelling evidence that TSG-6 has an in vivo role in the regulation of bone formation. Although we have demonstrated that TSG-6 can inhibit BMP-2-mediated osteoblast differentiation in vitro, we cannot rule out that TSG-6 may also affect the activities of other modulators of osteoblastogenesis (e.g.l-ascorbate and 1,25-(OH)-2-vitamin D3 (86, 87)), which will require further investigation.
###end p 66
###begin p 67
###xml 250 258 250 258 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 526 528 526 528 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref88">88</xref>
###xml 754 756 754 756 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref89">89</xref>
###xml 55 60 <span type="species:ncbi:10090">mouse</span>
###xml 362 366 <span type="species:ncbi:10090">mice</span>
###xml 520 524 <span type="species:ncbi:10116">rats</span>
###xml 547 550 <span type="species:ncbi:10116">rat</span>
In this study we have shown that TSG-6 is expressed in mouse knee joints, where the strongest TSG-6 immunostaining was associated with the cells in the epiphyseal and metaphyseal bone marrow and at the margins of bone marrow and trabecular bone. Our in vitro cell culture experiments are also consistent with TSG-6 being produced by bone marrow-derived cells in mice. OPG and RANKL have been shown to co-localize in the bone marrow lining cells, osteoblasts, and newly embedded osteocytes at sites of bone remodeling in rats (88). In addition, in rat tibiae, ALP activity (a marker of BMP-2-mediated differentiation) has been detected on osteoblasts and some bone marrow fibroblastic stromal cells, in particular those cells closest to the bone surface (89). These observations are indicative that TSG-6 is present within the bone marrow at similar localizations to BMP-2, RANKL, and OPG during bone remodeling.
###end p 67
###begin p 68
The above data have led us to hypothesize that TSG-6 might coordinately regulate the activities of osteoclasts and osteoblasts, thus having a key role in bone turnover. The molecular basis for these opposing functions and how they are differentially controlled remains to be determined. What is clear is that TSG-6 is a novel regulator of bone cell biology with potent effects on two processes that are central to both normal physiology and articular joint disease.
###end p 68
###begin title 69
Supplementary Material
###end title 69
###begin title 70
[Supplemental Data]
###end title 70
###begin p 71
We thank Dr. Phil Salmon (SkyScan, Belgium) for micro-CT analysis, Dr. Rachel Locklin (Nuffield Department of Orthopaedic Surgery, Oxford) for advice on ALP assays, and Marilyn Rugg (MRC Immunochemistry Unit, Oxford) for production of rhTSG-6 and the Western blot analysis.
###end p 71
###begin p 72
###xml 103 108 <span type="species:ncbi:9606">human</span>
The abbreviations used are: TSG-6, tumor necrosis factor (TNF)-stimulated gene 6; rhTSG-6, recombinant human TSG-6; SAB, standard assay buffer; ALP, alkaline phosphatase; BMP, bone morphogenetic protein; CUB, complement C1r/C1s, Uegf, Bmp1; CUB_C_TSG6, recombinant CUB_C domain of TSG-6; HA, hyaluronan; Link_TSG6, recombinant Link module of TSG-6; M-CSF, macrophage colony-stimulating factor; OPG, osteoprotegrin; PBMC, peripheral blood mononuclear cell; RA, rheumatoid arthritis; (s)RANKL, (soluble) receptor activator of NF-kappaB ligand; TGF-beta, transforming growth factor beta; WT, wild type; IL, interleukin; alphaMEM, alpha-minimum essential medium; PBS, phosphate-buffered saline; CT, micro-computerized tomography; ELISA, enzyme-linked immunosorbent assay; OPG, osteoprotegerin.
###end p 72
###begin p 73
D. C. Briggs, T. Ali, D. J. Mahoney, C. M. Milner, and A. J. Day, unpublished information.
###end p 73
###begin p 74
D. J. Mahoney, C. M. Milner, A. J. Day, and A. Sabokbar, unpublished information.
###end p 74

